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ABSTRACT
Sullivan, Brendan T. PhD, Purdue University, May 2016. Characterization of Cu-rich
aggregates in neurogenic niches of the rodent brain by X-ray fluorescence microscopy.
Major Professor: Yulia Pushkar.
Copper is an essential element in the brain playing several critical roles ranging
from neurotransmitter synthesis to ATP production. As Cu is typically present in
micromolar concentrations and has a spatially capricious distribution in the brain,
determining concentrations has historically been challenging. X-ray fluorescence microscopy (XRF) offers excellent spatial resolution (down to 30 nm) and detection
limits (sub parts per million), making it an excellent tool for analyzing metal distributions in the brain. Using XRF, it is demonstrated that Cu-rich aggregates with
concentrations in the hundreds of millimolar are present in the subventricular zone
of rats and mice. As the subventricular zone is a neurogenic niche in the adult brain,
the hippocampal dentate gyrus and rostral migratory stream were also examined to
see if these aggregates were present. It is shown that rats, but not mice, have Cu accumulations in the rostral migratory stream and dentate gyrus, which may be related
to the fact that the rat hippocampus produces more neurons and new neurons are
integrated more readily into neural circuits. In addition, these aggregates are found
in glial fibrillary acidic protein-positive cells and a lack of co-localization with bromodeoxyuridine suggests they are specifically in type-B progenitor cells in the SVZ.
Co-localization experiments with lysosomal associated membrane protein 1 and ubiquitin suggest that Cu aggregates are not simply awaiting autophagy but likely serve
some purpose. (XANES) spectra recorded directly from Cu aggregates in tissue show
that Cu is present as a Cux Sy multimetallic cluster and has the oxidation state Cu+ .
Consistent with being bound as a cuprous-thiolate cluster, Cu aggregates consistently
co-localize with sulfur with a molar ratio of [S]/[Cu] = 1.66 ± 0.07. By co-localizing

xix
XRF maps and DAB staining, it is shown that Cu and Fe form exclusive aggregates
in the subventricular zone that exhibit peroxidase or pseudoperoxidase activity.
Towards determining the role of Cu aggregates, the metal distribution in the
subventricular zone was examined under several conditions and insults. The subventricular zone is shown to selectively accumulate Cu with age owing in part to the
increase of Cu concentrations within aggregates. Metallothionein is a sulfur-rich protein known to be critical in Cu homeostasis in astrocytes cells. Metallothionein(1,2)
knockout mice exhibit lower subventricular Cu concentrations owed in part to the
fact that there are about one third as many aggregates in the SVZ and remaining
aggregates contain less Cu. As another metallothionein isoform – metallothionein 3 –
is present in the SVZ, it is likely that it fulfills the role of metallothionein(1,2). While
assignment is metallothionein as the binding protein is consistent with literature, its
exact role of the protein in aggregate formation remains unclear; metallothioneins
may simply facilitate Cu uptake into the cell. Exposure to Mn, which is known to
disrupt brain barriers, did not affect Cu concentrations for rats in either the subventricular zone or rostral migratory stream. Furthermore, the cuprizone mouse model,
which reproduces demyelination as observed in multiple sclerosis through dietary Cu
chelation, is examined. While X-ray diffraction mapping shows that myelin-rich areas
show diminished myelin there is no corresponding decrease in Cu in these regions, suggesting that Cu starvation may not be the mechanism behind demyelination. Dietary
Cu chelation by cuprizone did not affect metal concentrations in the subventricular
zone.
Taken together, the results demonstrate that periventricular Cu accumulations
are formed by a robust mechanism and likely serve some role. While the mechanism remains unclear, it is plausible that the aggregates somehow play a role in the
neurogenic activity in the regions they are present.
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1. Copper and the mammalian brain
The brain demonstrates an incredible capacity to accumulate Cu, exhibiting the highest concentrations of any tissue besides the liver [1]. Transition metals including Cu
are critical to numerous processes in the brain ranging from neurotransmitter synthesis to antioxidant defense. Similarly, perturbations to metal homeostasis have
been implicated in a wealth of diseases ranging from Alzheimer’s disease to Menkes
disease. As such, transition metals in the brain are tightly regulated both between
brain regions and within subcellular compartments. The aim of this section is to
provide and overview of the roles that Cu plays in the brain as well as the machinery
regulating brain Cu homeostasis. Additionally, since much of the work presented in
the thesis will be examined with respect to neurogenesis in the subventricular zone,
a short introduction is given in Section 1.5.

1.1

The roles of copper in the healthy brain
Copper is responsible for many cellular and extracellular processes in the brain.

An (incomplete) list of non-transporting Cu-binding proteins present in the brain
is presented in Table 1.1. A common role for Cu in cuproproteins is to act as an
oxidoreductase. As an important example, consider superoxide dismutases 1 and 3
(SOD) which can neutralize superoxide (O−
2 ) by the following half-reactions:
+
Cu2+ −SOD + O−
2 → Cu −SOD + O2
+

Cu −SOD +

O−
2

+

(1.1)

2+

+ 2H → Cu −SOD + H2 O2

Superoxide is regularly generated as a byproduct of several brain functions (e.g. by
mitochondrial respiration [2]) which will ultimately lead to cell death if not rendered
into a more stable form [3]. As a result, the importance of SOD and proper Cu

2
homeostasis cannot be overstated. Mutations to Cu,Zn SOD, for instance, have been
strongly implicated in familial amyotrophic lateral sclerosis (FALS) [4].
Table 1.1.
Copper binding proteins and assumed functions
Protein

Assumed Function

References

Cytochrome c oxidase

ATP Production

[5, 6]

Metallothionein

See Section 1.4

[7–9]

Dopamine β-hydroxylase

Neurotransmitter synthesis

[10, 11]

Ceruloplasmin

Fe metabolism

[12]

Cu,Zn Superoxide Dismutase

Antioxidant defense

[13, 14]

Lysyl Oxidase

Collagen and Elastin Production

[15, 16]

Prion

Unknown

[17–19]

Amyloid Precursor Protein

Unknown

[20–22]

α-Synuclein

Unknown

[23–25]

Another critical example of Cu’s role as an oxidoreductase in the brain is during
ATP production. Cellular respiration in the brain occurs primarily in mitochondria,
with estimates that more than 90% of the brain’s energy is generated by mitochondria
[26, 27]. The mitochondrial pathway to ATP production is driven by an electron
transport chain that energetically enables ATP production by ATP synthase:

ADP + Pi + Energy → ATP

(1.2)

The final step in the electron transport chain is carried out by the transmembrane enzyme cytochrome c oxidase which contains 2 Cu sites [5] serving as electron acceptors
from cytochrome c and enabling oxidation of the previously reduced cytochrome c [28].
This reaction is critical in maintaining cellular metabolism in all forms of life. The
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importance in the brain is emphasized in situations when Cu availability prevents
proper cytochrome c oxidase activity (Section 1.3).
The role of Cu as an oxidoreductase also renders Cu homeostasis important to cell
signaling. The dependence of Cu availability on cell signaling arises by several mechanisms. First, Cu can be present at the active site of enzymes related to signaling. As
an example, dopamine β-hydroxylase (DBH), responsible for converting dopamine to
norepinephrine, has two Cu ions at its active site and functions as an oxidase in the
reaction [10,11]. Secondly, exogenous Cu2+ has been shown to act as an antagonist to
a variety of signalling receptors including γ-aminobutyric acid (GABA) [29, 30] and
N-methyl-D-aspartate (NMDA) [31]. Finally, Cu can affect signaling by managing
cellular oxidative stress which, in turn, affects transporter and receptor expression.

1.2

Copper transporting, trafficking, and storage in the brain
Having examined a handful of critical physiological roles of Cu in the brain, it

is evident that healthy brain function relies heavily on Cu being delivered to the
correct proteins. As unbound Cu ions would pose a serious threat to cells by inciting
an avalanche of oxidative species – indeed the average yeast cell was found to have
less that one free Cu ion per cell [32] – Cu must be carefully escorted to the correct
cells and proteins. This is done by transmembrane Cu transporting proteins and
cytosolic Cu chaperone proteins. First, Cu must be uptaken into the brain from
either the blood-brain barrier (BBB) or blood-cerebrospinal fluid barrier (BCFB),
both of which have been shown to transport Cu primarily as a free ion [33, 34]. A
pictorial representation of the process is given in Figure 1.1.
Copper uptake into the cell has been shown to be primarily done by copper transporter 1 (CTR1) [35,36] in ex vivo experiments, which is emphasized by the fact that
CTR1 knockout is embryonically lethal [37]. DMT1, however, is capable of transporting Cu across the cell membrane [38]. Upon entry to the cell, Cu ions are sequestered
by chaperones for transport to their protein destination or are sequestered by glu-
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CTR1
DMT1
COX17
GSH
MT

Sco1/2
COX11

Cu+
Atox1
CCS
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ATP7A

ATP7A
ATP7B

Golgi

CCO
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Cell

ATPase

Other
Protein

SOD

Cuproproteins
for Use

Transporter

Organelle
Cuproproteins
for Export

Figure 1.1. Diagram of the major proteins involved in Cu transport.
Abbreviations are given in the abbreviations list in the front matter.

tathione (GSH). While only a handful of copper chaperones have been identified,
they all share similar structural motifs and are conserved across different kingdoms
highlighting their importance [39, 40]. The major chaperones are shown in Figure
1.1. Studies of chaperone knockout mice have demonstrated the importance of these
proteins. Knockout mice for copper chaperone for superoxide dismutase (CCS), for
instance, show no growth defects through adulthood, but female mice exhibited di-
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minished fertility [41]; it is possible that other antioxidant defenses or glutathione
(GSH) can compensate for the lack of activated Cu/Zn SOD. Other transporters are
more critical. Antioxidant protein 1 (ATOX1) knockout mice, for instance, exhibit
severe growth defects and seizures [42] while cytochrome c oxidase copper chaperone
(COX17) knockout is embryonically lethal due to decreased mitochondrial respiration [43].
Within the cell, it is necessary to transport Cu ions across membranes either for
cellular export or delivery to the trans-Golgi network. This is achieved primarily
by ATP7A and ATP7B. ATP7A and ATP7B are transmembrane proteins that rely
on ATP hydrolysis to actively pump Cu ions across the membrane [44]. ATP7A and
ATP7B are critical to preventing dangerous cellular concentrations of Cu and ensuring
that the ion can be incorporated into proteins. Loss-of-function mutations to ATP7A
and ATP7B manifest themselves as Menkes and Wilson’s diseases, respectively, which
are discussed in more detail in Section 1.3.
While the in vivo onus of Cu transport across brain barriers is not unambiguously
defined, [45], there is strong evidence that astrocytes are responsible for uptake across
the brain barriers. Astrocytes heavily regulate the properties of the blood brain
barrier [46] and have the ability to uptake metals through their perivascular endfeed
[47] via CTR1 and possibly DMT1 [33]. Similarly, it has been demonstrated that
type-B progenitors, a subset of periventricular astrocytes (see Section 1.5), retain
contact with the blood cerebrospinal fluid barrier [48], allowing preferential access to
Cu at the barrier. As such, it has been proposed that astrocytes can serve as Cu
“depots” for the brain [49, 50] by accumulating metal which can be later used by the
astrocyte or routed to neurons. Supporting this argument, it is important to note
that astrocytes, at least in culture, are capable of Cu uptake [51] and export, likely
via an ATP7A-dependent pathway [52].
In addition to their fortuitous placement along brain barriers, astrocytes exhibit
impressive Cu storage abilities. The storage capacity is achieved through a combination of GSH and metallothioneins. GSH is a tripeptide of glutamine, cysteine,
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and glycine that has been implicated in antioxidant activity, redox signaling, metal
sequestration, and cell cycle regulation [53] that is preferentially present in astrocytes [54]. The malleable structure of GSH renders it capable of binding transition
metals, including Cu. Additionally, it has been shown that Cu-GSH can act as a
chaperone for several proteins. Metallothioneins (MTs) are a class of cysteine-rich
proteins that bind up to twelve metal ions (see Section 1.4). Of particular interest for
Cu storage is the fact that GSH has been shown to deliver Cu to MT [55]. It is widely
believed that astrocytes’ ability to effectively store Cu lies in quick sequestration by
GSH with long term storage being fulfilled by MT, enabling timely delivery of Cu as
needed. Copper concentrations have also been shown to regulate the expression of
MT and GSH, making them excellent storage solutions as they can be produced on
an as-needed basis.

1.3

Copper and disease
Given the important roles Cu fulfills and the the degree to which its transport

is regulated, it is unsurprising that dysfunction in Cu handling machinery leads to
disease. Menkes disease, for instance, occurs as a result of ATP7A deficit [56]. These
disease, first published by Menkes in 1962 [57], affects patients through developmental
retardation, muscle weakness, seizures, and wiry, brittle hair; patients rarely live last
three years of age. Without adequate functioning ATP7A, Cu cannot be correctly
uptaken from food in the small intestine nor can it be delivered to cuproenzymes in particular cytochrome c oxidase deficiency has been proposed as a major source of
Menkes symptoms [58]. The disease is currently untreatable, though subcutaneous
Cu delivery has had limited clinical success in mitigating the effects. Intraventricular injections of viruses harboring ATP7A have been shown to aid significantly in
extending the life of mottled brindled mice (a Menkes model) and increasing cuproenzymatic activity, suggesting that gene therapy may be a viable pathway for human
treatment [59].
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Wilson’s disease, on the other hand, is a Cu overload condition. First described
in a monograph by Wilson in 1912 [60], the Cu overload was shown to be caused by
mutations to ATP7B [61]. After dietary uptake, Cu is transported to the liver. In
the liver, ATP7B is responsible for 1) packing Cu into ceruloplasmin for release into
blood and 2) biliary excretion of excess Cu; deficient ATP7B then results in excess
Cu accumulating in organs, including the brain [62]. Symptoms include cirrhosis of
the liver, depression, neuroses, and Parkinson’s-like symptoms. Wilson’s disease is
detectable by liver biopsy and by measuring ceruloplasmin and copper concentrations
in blood and urine. Copper chelation therapy has proven successful in mitigating the
effects of Wilson’s disease and, in extreme cases, liver transplants can recover Cu
homeostasis.
Cu is also implicated in a number of aggregate-based diseases. As an example,
Alzheimer’s disease – caused by the formation of insoluble amyloid plaques – are
known to nucleate around Cu and Zn centers and indeed retain the metals in high
concentration [22, 63, 64]. There is a growing body of evidence that Cu’s binding
with α-synuclein accelerates the aggregation process [65], promoting the formation
of Lewy bodies and ultimately Parkinson’s disease. Cu homeostasis is also thought
to play a role in prion diseases – caused by the misfolding of the prion protein (PrP)
into its pathogenic, scrapie form (PrP Sc) – though the etiology is not yet clear [66].
Copper is known to compete with Mn for binding in PrP and the latter is known
to induce oligimerization [67]. One possibility, then, is that Cu occupies sites that
would otherwise be occupied by Mn and prevents rapid polymerization [68]. In each
of these cases, the relationship between Cu and aggregate formation remains somewhat unclear, but metal binding may induce conformational changes that promote
oligimerization which leads to aggregation.
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1.4

Metallothioneins
Central to Cu homeostasis in the brain is metallothionein (MT). Metallothioneins

are a class of cysteine-rich proteins that have been implicated in numerous brain
functions. While MT was originally reported from equine kidney in 1957 [69] it was
eventually determined to be ubiquitous amongst mammals and even present in some
plants and prokaryotes [7]. There are four distinct isoforms of metallothionein, named
MT1, MT2, MT3, and MT4. In mammals, MT1 and MT2 are expressed ubiquitously
through the body while MT3 is expressed primarily in the central nervous system
and MT4 is not expressed in the nervous system [70]; MT1 and MT2 are expressed
preferentially in the astrocytes while MT3 is expressed primarily in neurons, though
all three isoforms have been detected in each cell type [71].
Metallothionein’s ability to bind up to twelve metal ions has been attributed to
two distinct metal binding domains, one β strand and one α helix which bind metals
using highly conserved cys-cys, cys-x-cys, and cys-x-y-cys residues [72]. These motifs
have been attributed to metallothionein’s high metal binding affinities; Cu+ has been
shown to have the highest affinity (1017 –1019 ) followed by Cd2+ (1015 –1017 ) and Zn2+
(1011 –1014 ) [73].
While the importance of MT to metal homeostasis, and therefore oxidative stress,
has been recognized, a primary function aside from metal sequestration is yet to be
determined. Within the brain, metallothioneins have been implicated in several processes. MT(1,2) knockout (MTKO) mice, for instance, are unable to quickly recover
from cortical injuries or induced seizures, implicating MT in activating astrocytes
and forming a glial scar around affected areas [74–76]. The neuroprotective role of
metallothionein may also be a result of being exported from astrocytes and interacting with neurons [77, 78]. MT is also thought to be critical in managing apoptosis.
One realization of this is by preventing release of cytochrome c from mitochondria,
thereby preventing the caspase cascade route to cell death [79].

9
1.5

Neurogenesis in the adult subventricular zone
It was a long-held belief that the developed brain was a static structure; that is to

say that after development no neurons could be produced. That belief was overthrown
with Altman’s 1962 seminal paper in which radioactively labeled thymidine was used
to mark cells that had undergone division in adulthood [80]. Further studies showed
that adult neurogenesis is a common trait in the mammalian brain [81] including
humans [82]. Adult neurogenesis has been demonstrated in the subventricular zone
(SVZ) and dentate gyrus (DG) of the hippocampal formation (HPCf). In the subventricular zone, a subset of glial fibrillary acidic protein (GFAP+) astrocytes are the
neural stem cells [83] with offspring capable of eventually becoming neurons, astrocytes, or oligodendrocytes [84]. These cells then migrate along the rostral migratory
stream (RMS, see Figure 2.7) to the olfactory bulb, differentiating along the way.
There are four major cell types involved in the process of proliferation, migration,
and differentiation [83]:
• Type A migrating neuroblasts are fast moving neural precursor cells derived
from type C cells. Neuroblasts are lineage committed to become a neuron, but
are still capable of division unlike neurons, which are postmitotic.
• Type B slow-progenitor cells are the GFAP+ progenitor cells1 in the subventricular zone. These cells define the migratory pathway to the olfactory bulb
and a subset of these cells have been shown to be neural stem cells [85].
• Type C transit amplifying cells are derived directly from type B progenitors
and will ultimately give rise to neuroblasts. Type C cells retain multipotency
that can be activated in the presence of growth factors [86].
• Type E ependymal cells make direct contact with the ventricle and have cilia
which serve to absorb and circulate cerebrospinal fluid. The choroid plexus is
1

A lack of in vivo markers for true neural stem cells has given rise to the term “progenitor cell”,
which is used to describe cells with some differentiation potential, though these cells may not strictly
be true stem cells.
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composed primarily of modified ependymal cells. Ependymal cells have also
been shown to capable of neuron production, but are eventually depleted.
Following differentiation into neurons, survival and functional integration into neuronal circuits are also issues. While these are beyond the scope of the work here,
reviews on the subjects are available.
There are a wealth of factors influencing cell proliferation in mice. Empirically, it
has been demonstrated that exercise, stress, and sleep can all affect neurogenic rates,
though the biochemical mechanism is not clear [87]. Exogenous application of many
chemical agents including growth factors, cytokines, and neurotransmitters have all
been reported to modulate neurogenic rates (which are nicely reviewed in [88].) The
exact mechanisms by which those affect cell proliferation in neuroproliferative zones
remains elusive. In mice models, primarily from ex vivo studies, it has been shown that
a central component in maintaining cellular potency is the canonical Wnt signalling
pathway. The pathway is reviewed extensively in [89]. Briefly, the canonical pathway
involves Wnt, a signalling protein, binding to a frizzled (fzd) transmembrane receptor.
The Wnt-fzd pair results in cytosolic accumulation and a subsequent translocation of
β-catenin to the nucleus. In the nucleus, β-catenin binds to T-cell factor/lymphoid
enhancing factor (TCF/LEF) transcription factors. In murine stem cells, activation
of the canonical Wnt pathway has been shown to upregulate STAT3 and prevent
progenitor differentiation, instead promoting self-renewal [90, 91]. It should be noted
that in humans, STAT3 is not sufficient for self renewal [92]; Wnt is still thought
to be important in human stem cell differentiation through mechanisms still under
investigation.
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2. Methodologies
2.1

Methods for mapping brain metal distributions
Having established the importance of mapping metal distributions in the brain, it

is worthwhile to consider the challenges involved in measuring said distribution. In
practice, there are three technical hurdles that must be overcome in order to reliably
map metals in the brain. First, it is imperative that elements can be distinguished
from other elements (e.g. differentiating Cu and Zn). Secondly, as concentrations
are often in the micromolar range, the ideal method would have very high sensitivity.
Finally, as discussed in Chapter 1, the brain exhibits a very capricious metal distribution and so high spatial sensitivity is required while still allowing measurements to
be made over entire brain regions. Table 2.1 has an overview of pertinent parameters
for elemental imaging in biological systems. Those more pertinent to brain imaging
are discussed below. For a more complete discussion, the reader is referred to [93].
Table 2.1.
Limits of current elemental imaging techniques
Technique

Detection Limit Spatial

Resolu- Penetration

(µg/g)

tion (µm)

Depth (µm)

XRF

0.1-1

0.03+

>100

PIXE

1-10

0.2-2

10-100

EDS/EDX

100-1000

0.03

0.1-1

EELS

1000

0.001

<0.05

LA-ICP MS

0.01

5+

200

SIMS

0.1

0.05

0.1

Radioisotopes

n/a

50-100

>1000
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2.1.1

X-ray fluorescence microscopy (XRF)

X-ray fluorescence occurs when a non-valence electron is removed from the atom
(in this case by X-ray bombardment) creating a core hole. This core hole is then filled
by a higher energy electron and, in doing so, emits a photon with an energy equal to
the energy difference between those two states (Figure 2.1). A diagram of transitions
through the N shell is given in Figure 2.1. Transitions obey quantum selection rules.
For the dominant electric dipole (E1) transition, these are given by
∆n ≥ 1
∆l = ±1

(2.1)

∆j = ±1
Furthermore, cross section calculations have shown K-shell fluorescence to dominate
L and M-shell fluorescence [94]. Consequently, XRF measurements are dominated by
p → s transitions - i.e., Kα fluorescence. Other transitions are observed but have
relatively low yields.
There are several requirements for a beamline to conduct a productive X-ray fluorescence microscopy experiment for trace elements in biological systems. First, X-rays
must be produced with an energy above the absorption edges of interest and with adequate flux to allow timely measurements. For biological trace metal investigations,
interest primarily lies in Cu, Fe, Mn, and Zn, whose K edges are given in Table 2.2.
For the metals pertinent to this project (Table 2.2), an incident energy of 10 keV
is adequate; conveniently, many microbeam imaging beamlines obtain high flux at
10 keV. If gold immunostaining (see Section 2.4) is being employed, Au is excited
at the Au L edge (d to p orbital fluorescence), at 11.92 keV; these experiments are
typically carried out with an incident energy of 13 keV for results shown in this work.
Secondly, the incident beam must be focused to an appropriate size. Focusing, described in Section 2.3.2, is achieved using either a zone plate, a compound refracting
lens (CRL) or Kirkpatrick-Baez (KB) mirrors. In practice, each beamline has optics
tailored to a specific spot size and so the required resolution for an experiment de-
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Figure 2.1. Left: Mechanism behind X-ray fluorescence. (1) A core
electron is ejected by the incident X-ray and (2) filled by a higher
lying electron. One such decay path is the release of a fluorescent
photon. Right: Diagram showing allowed transitions and their name
in Siegbahn notation. Energies are not drawn to scale.

termines at which beamline an experiment should be carried out. Lastly, a means to
record the fluorescence with energy resolution that can resolve individual elements is
necessary. In the work presented here, this is done with an energy dispersive silicon
drift detector (Section 2.3.3). To make XRF measurements quantitative the recorded
spectra must be compared with a known standard. In principle, any thin film containing the metal of interest at a known concentration is sufficient for normalization.
In all data from the APS reported in this paper, either the (now obsolete) NBS1832
and NBS1833 thin film standards or AXO Thin Film XRF references are used for
absolute concentration calibration. Information on the standards is available in [95]
and from Axo-Dresden GmbH (Dresden, Germany), respectively.
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Table 2.2.
Edge and fluorescence energies of elements for brain imaging
Element

2.1.2

K edge

Kα

Fluores- Kβ

cence

cence

Fluores-

P

2.15 keV

2.02 keV

2.14 keV

S

2.47 keV

2.31 keV

2.46 keV

K

3.61 keV

3.31 keV

3.59 keV

Ca

4.03 keV

3.69 keV

4.01 keV

Mn

6.53 keV

5.90 keV

6.50 keV

Fe

7.11 keV

6.40 keV

7.06 keV

Cu

8.98 keV

8.05 keV

8.94 keV

Zn

9.66 keV

8.64 keV

9.57 keV

Energy dispersive spectroscopy (EDS)

Energy dispersive spectroscopy (EDS) operates on the same principle as XRF a fluorescence photon is emitted and recorded by an energy-sensitive detector. The
only difference is that a focused beam of electrons are used as an excitation source
rather than X-rays. The principle advantage of EDS is that it is routinely performed
using electron microscopes, which are commercially available and access is relatively
common. As such, very high spatial resolution (∼30 nm) is readily achievable and
access to equipment is not a concern.
The downside, however, lies in the detection limits (Table 2.1). Biological metal
concentrations often fall in the µM range, below what can be reasonably detected by
EDS. Furthermore, the low penetration depth of electrons in tissue sections (<1 µm)
does not allowing sampling through entire cells in tissue sections. The issue of penetration depth can be circumvented by analyzing serial sections with thicknesses on
the order of the penetration depth, which is commonly done in studying the ultra-
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structure of the brain [96–98]. However, these approaches typically require fixation
for sectioning and/or osmium staining for visualization, and as such will redistribute
metal in the brain. As a result, XRF is preferred for imaging dilute biological systems
such as brain sections.

2.1.3

Electron energy loss Spectroscopy (EELS)

Electron energy loss spectroscopy (EELS) is an imaging technique that determines
elemental composition by measuring the energy lost when electrons inelastically scatter off the sample. In principle, EELS can provide information down to the atomic
level [99]. However, the limited penetration depth (50 nm) and high detection limit
renders it of limited use in tissue imaging. Even for single cell imaging, special treatment for ultra-thin section preparation and osmium staining for contrast can alter
physiological metal concentration and localization.

2.1.4

Laser ablation induced coupled plasma mass spectrometry (LA-ICP
MS)

Laser ablation induced coupled plasma spectrometry (LA-ICP MS) is an analytical
technique in which a tightly focused, high power laser beam ablates the sample. The
resulting particles are then ionized, typically by a plasma torch, and analyzed for
elemental composition via mass spectrometry. By scanning the sample and measuring
over a grid of points, elemental maps can be formed. It is noted from Table 2.1 that
LA-ICP MS has superior detection limits and comparable penetration depth to XRF.
The current limitation for LA-ICP-MS is spatial resolution. Currently achievable
resolutions are a matter of technological limitations; the only fundamental limitation
is the laser spot size which can be focused to roughly the wavelength of ablating light
(often around 200 nm.) It should be noted, however, that there is a tradeoff between
spot size and detection limits [100]. Owing to its wide field of view, low detection
limits, and the fact that chemical treatment is not necessary for sample preparation,
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LA-ICP MS has been used for imaging a wide range of biological systems [101–103],
including the brain tissue [100, 104, 105].

2.2

High-resolution X-ray diffraction mapping as an imaging modality
Complementary to XRF measurements are X-ray diffraction mapping experi-

ments. By recording a diffraction image at each point on a grid covering a brain
section, it is possible to record a wealth of structural information directly from brain
sections. One particular application of diffraction mapping in the brain is to analyze
the fiber patterns produced by myelin and neurofilaments. Myelin, the insulating
material surrounding neuronal axons, has a lamellar structure with a repeat of quasiperiodicity of 173 Å [106] while neurofilaments are intermediate filament proteins
comprising the cytoskeleton of neurons that assemble into tetramers that repeat every 220 Å [107]. The constitution of these structures are critical to healthy neuronal
signaling in the brain and their dysfunctions have been associated with a variety of
diseases ranging from multiple sclerosis to amyloid lateral sclerosis.
Fiber diffraction patterns for both of those structures can be observed by recording
diffraction in the 10 Å − 120 Å range, as done in this work. It is common to observe
two rings from brain sections over that range of d – one at ≈ 43 Å and one at ≈ 58 Å.
The former is associated with the fourth order reflection of myelin while the latter
is a convolution of myelin’s third order reflection and the fourth order neurofilament
reflection. The resulting diffraction image for each pixel is analyzed in two ways.
First, it can be integrated radially. This results in a curve containing a peak for each
observed diffraction ring in addition to some background. By assuming a functional
form for both the background and the peaks, this curve can be fit; for simplicity the
present work assumed a linear background and that peaks are shaped as Gaussians:
A1 e

(d−d¯1 )
2
2σ1

+ A2 e

(d−d¯2 )
2
2σ2

+ Bd + C

(2.2)
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Once the profiles are fit (Figure 2.2D-F), the parameters can be used to create spatial
maps (Figure 2.2G). The amplitude Ai , for instance, reports on the concentration of
the species being fit (e.g. myelin).
Additionally, each ring may be azimuthally integrated to reconstruct the spatial
orientation of each fiber (Figure 2.3). A geometric description of the azimuthal profile
was described in 2003 by Paris and Müller [108]. In brief, the model gives a description
of the intensity I as a function of phi, the polar coordinate on the detector face:
I(φ) = I(Ψ(φ))
(2.3)
−1

Ψ(φ) = cos (cos θ sin µ cos φ − sin θ cos µ)
With µ is the angle of the fiber axis with respect to the beam and the diffraction ring
is observed at a diffraction angle 2θ. Then, assuming a Gaussian distribution of fiber
orientations whose diffraction maxima form at φ0 and have a standard deviation σφ
and a background B, each ring profile can be fit as:
π

I(φ) = Aφ exp(− 2

− (cos−1 (cos θ sin µ cos(φ − φ0 ) − sin θ cos µ))2
) + Bφ
2σφ2

(2.4)

To construct azimuthal profiles, rings are binned into angular bins (Figure 2.3B) and
the mean counts of pixels in that bin is taken. Fits are carried out as non-linear
least squares fits to data and fit quality is monitored by the sum of squared residuals.
Radially and azimuthal fits were done separately with the radial fit being done first
as the azimuthal fit depends on the resulting θ. Without peaks (e.g. Figure 2.3D),
these profiles are described equally well by a large background Bφ with low amplitude
Aφ or by very low background with a very broad distribution (large σφ ). Physically
these reduce to the same situation: a randomly oriented set of fibers in the sampled
voxel. To remove this mathematical ambiguity, the bounds on azimuthal background
are placed just below the mean intensity forcing a solution with high background.
A representative orientation map of myelin around the ventricle is shown in Figure
2.3E,F.
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Figure 2.2. Radial Integration to form diffraction maps. A,B,C. Representative diffraction images from different regions of a scan. The
corpus callosum (A) has very high myelin concentrations, the anterior olfactory nucleus (B) which does not have an elevated myelin
concentration, and the mylar substrate (C) which should be devoid of
any myelin or neurofilaments. D-F. Radially integrated intensities for
images A-C (blue dots) and their fit to a double Gaussian model (red
line). G. The amplitude of the Gaussian at d ≈40 Å(corresponding
to myelin) plotted to form a myelin map with a pixel size of 100 µm.
Inset letters correspond to diffraction images A-C. H. d spacing map
of the same image.
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Figure 2.3. Azimuthal integration for fiber orientation determination.
A. Schematic representation of azimuthal integration. Each ring can
be integrated as a function of φ around the ring and the resulting intensities will show any preferred orientations. B. Heat map of pixels
to be considered for integration of two rings with the color representing the angle assigned to it. C. Example of fitting with a strong
preferred orientation. Mean counts is shown in black dots with the
fit of the Paris model in red. D. Example of fitting of a ring with no
strongly preferred orientation. E,F. Myelin intensity maps from a rat
brain (E) and the orientation map from the same scan (F) showing
that this fitting scheme can reliably detect fibers preferred orientation
while maintaining spatial information.

2.3

Synchrotron radiation for X-ray microscopy
A typical X-ray microscopy experiment requires 1) an X-ray source, 2) a monochro-

mator, 3) a focusing mechanism, and 4) a detector. Owing to the dilute nature of
metals in biological systems, table-top X-ray sources make experiments prohibitively
time consuming and so only synchrotron experiments will be considered here. For a
more complete description, the reader is referred to [109].
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2.3.1

X-ray production

Synchrotron radiation refers to X-rays generated by accelerating electrons traveling at relativistic speeds. Electron bunch acceleration is typically achieved by smaller
accelerators prior to injection into the main storage ring. At the Advanced Photon
Source, for instance, a linear accelerator and booster ring accelerate bunches to 7 GeV
(γ ≈ 13, 700) prior to storage ring injection .
Once in the main storage ring, electrons are accelerated transverse to their direction of propagation to produce X-rays. X-ray production done by either an insertion
device (ID) or bending magnet (BM), the former being designed explicitly for X-ray
production and the latter for steering of electrons around the storage ring with Xray production as fortunate consequence. Insertion devices are a series of magnets
arranged to induce transverse oscillations in the electrons’ trajectories. For an electron moving in the ẑ direction being perturbed in the x̂ direction due to a periodic
magnetic field in the ŷ direction, an electron’s motion can be described by a Lorentz
force:
dp
= −e(E + v × B)
dt

(2.5)

A series of alternating magnets are used to perturb the motion, so the assumption
E  B is reasonable:
dp
≈ −ev × B
dt

(2.6)

Furthermore, electrons are moving at very near the speed of light along ẑ, such that
v ≈ vz . Assuming a periodic magnetic field from the alternating magnets of the form
B = By = B0 cos(2πz/λ) then equation the transverse equation of motion becomes:

mγ

dvx
dz
2πz
= e B0 cos(
)
dt
dt
λ

(2.7)

Integrating both sides:
Z
mγvx =

eB0 cos(

2πz
)dz
λ

(2.8)
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This leads to the transverse velocity:
mγvx = [

eB0 λ c
2πz
] sin(
)
2πmc γ
λ

(2.9)

The bracketed quantity is known as the deflection parameter, K:
K≡

eB0 λ
= 0.9337B0 λ
2πmc

(2.10)

with B0 given in units of T and λ in cm. IDs with K  1 are known as wigglers
and produce radiation exhibiting a time-varying ”search light” pattern with a broad
spectrum [110]. IDs with K  1 are known as undulators and have very small
angular variance in their radiation and exhibit sharply peaked spectra. For these
reasons, most modern ID beamlines use undulators to generate X-rays.
Ignoring the electron’s energy loss while passing through an undulator, γ will be
constant:

vz2
1
vx2
=1− 2 − 2
c2
γ
c
1
K2
2πz
= 1 − 2 − 2 sin2 (
)
γ
γ
λ
Or, after some rearrangement assuming a small K/γ:
vz
1 + K 2 /2 K 2
2πz
=1−
+ 2 cos(2 ·
)
2
c
2γ
4γ
λ

(2.11)

(2.12)

Which contains an average velocity and a double-frequency term. The latter gives
rise to interference pattern. In the time it takes the electron to travel one period
(λ/v) the previous wavefront has propagated (λc/v). So an observer at an angle θ
from the ẑ axis will see a path length difference of:
δ=

λc
− λ cos(θ)
vz

(2.13)

Imposing of constructive interference condition:
λc
− λ cos(θ) = nλrad
vz

(2.14)

with λrad the observed radiation wavelength. Taken with Equation 2.12 and assuming
a small angle θ, one arrives at the well-known undulator equation:
λrad =

λ
K2
(1
+
+ γ 2 θ2 )
2
2nγ
2

(2.15)
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One can also consider the wavelength spacing between constructive and deconstructive interference. It can be shown that with N magnets comprising the undulator:
∆λ ∼

λ
Nn

(2.16)

If one assumes a purely monochromatic source, it is also possible to find the deconstructive condition for θ that defines the divergence of the beam. It can be shown
that:

r
∆θ =

2λrad
Nλ

(2.17)

More particularly, by Lorentz transforming classical dipole radiation from the
electron’s rest frame to the laboratory frame, it can be shown that the half-angle of
the radiation cone produced, θrad is:
1
θrad ≈ √
γ N

(2.18)

A critical result (Equation 2.15) is that the observed radiation λrad ∼ 1/γ 2 . For
electrons at γ = 10, 000, this corresponds to a reduction of 10−8 between the undulator’s magnet spacing and the observed wavelength. In other words, centimeter
periodicity in magnets can give rise to angstrom-scale radiation. The reduction has
been critically exploited in the design of third and upcoming fourth generation synchrotron sources. Furthermore, Equations 2.16 and 2.18 make clear another feature of
undulators: they produce relatively monochromatic and low-divergence X-ray beams.
For these reasons, they are preferred at modern beamlines.
Bending magnets are devices designed to steer electron bunches around the storage
ring. In doing so, they also produce radiation. A simplified description of a bending
magnet is that it is an undulator with N < 1 total periods. Consequently, the
bandwidth which goes as 1/N (Equation 2.16) gets very broad while the divergence,
√
which goes as 1/ N (Equation 2.18) grows quite large. Often bending magnets
are characterized by their critical photon energy Ec - the (laboratory frame) photon
energy at which half the of the radiated power is above and half is below. The critical
energy is given by [109]:
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Ec =

3eh̄Bγ 2
2m

(2.19)

The large divergence and broad bandwidth are undesirable for many X-ray experiments, especially elemental imaging, as they ultimately lead to reduced flux being
delivered to the sample. With recent advances in beamline components, however, it
is possible to use bending magnet beamlines to measure very dilute concentrations.

2.3.2

Focusing: KB mirrors, compound refracting lenses, and zone plates

Dating back to Röntgen’s initial experiments with X-rays, it had been known that
X-rays could not be readily focused with traditional lenses. The difficulty, it was later
realized, lies in most materials having either real indices of refraction trivially different
from 1 and/or because they are strong absorbers in the X-ray regime. Prior to the
announcement of grazing-angle X-ray mirrors in 1947 by Ehrenberg [111] and their
practical realization by Kirkpatrick and Baez [112], it was widely believed that X-rays
could not be focused by mirrors or lenses. Widespread interest in microfocused X-ray
experiments, however, pushed the development of several focusing mechanisms. This
discussion is intended to be a brief introduction to each of these methods. In the
interest of completeness, it is noted that capillary optics have also been used to focus
X-ray beams [113–115] but are not discussed here.
The earliest reported focusing of X-ray beams was by so-called Kirkpatrick-Baez
(KB) mirrors [112]. While significant advances have been made in the manufacturing
of KB mirrors since their report 1948, the focusing principle remains the same. Two
mirrors, one for horizontal and one for vertical focusing, are bent elliptically such
that they have a common focal point. The geometry of focusing is similar to that of
traditional mirror focusing and are not discussed here.
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Compound refracting lenses (CRLs) use a series of holes bored through some
material to effectively create a series of lenses. The index of refraction for materials
in the X-ray regime can be written as
n = 1 − δ + iβ

(2.20)

with δ being the differential real index of refraction and β the absorption index. The
trouble with forming traditional lenses lies in the fact that δ ≈ 0 for most materials
with non-trivial absorptions. A CRL is a series of holes bored in a material with the
area between holes acting as a series of lenses (Figure 2.4). With the focal length of
a CRL is given by [116]
F =

R
2N δ

(2.21)

with R being the radius of the lens and N being the number of lenses. For example,
aluminum at 10 keV has δ = 5 × 10−6 . Consider a single aluminum lens, N = 1,
with a realizable radius of R = 200 µm. This lens’ focal length is a 17.4 m - an
impractical distance for many beamlines. By placing many lenses in serial, however,
this distance quickly shortens. With 5 holes, for instance, the focal length becomes

X-rays

3.5 m, a workable distance.

R

R

R

N
...

R

Behaves like a lens
Figure 2.4. Schematic of a compound refracting lens (CRL).

Zone plates, in contrast, rely on diffraction to focus the incident X-ray beam.
First described by Fresnel in 1866, a zone plate is a series of concentric rings with
alternating transparent and opaque rings (Figure 2.5A) that focuses the incident
beam. The geometry for the nth ring is shown in Figure 2.5B. For a source at point
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A focusing at point B, the required radii are readily calculated by imposing the
condition that the nth and n + 2nd ring constructively interfere. The path length
differences are given by:
p

rn2 + a2 − a
p
δ2 = rn2 + b2 − b

δ1 =

(2.22)

A
B

δ 1 δ2
rn

a

A

a

b

b

B

r2

r4

r2n

Figure 2.5. Schematic of a zone plate. A. Drawing of a zone plate,
which consists of alternating dark and transparent layers concentric
rings. The farther rings are from the center, the narrower rings have to
be to achieve focusing. B. Figure illustrating the path length different
for the nth ring.
rendering the total path length ∆:

∆ = δ1 + δ2 =

p
p
rn2 + a2 + rn2 + b2 − a − b

(2.23)

Imposing deconstructive interference requires that ∆ = nλ/2. After some rearrangement and assuming a small wavelength (λ  rn ), one arrives at the edge of the
nth radius:

26

rn2 ≈ nλb +

n2 λ2
4

(2.24)

which gives the edge of the nth zone plate ring. The maximum attainable resolution
of a zone plate, of course, is diffraction limited. Consequently, the Rayleigh criterion
defines the maximum resolution. To resolve two objects a distance w apart:
w = 1.22∆rmax

(2.25)

Differentiating Equation 2.24 it is clear that zone thickness (∆r) must become
thinner as n increases to achieve focusing. In practice, the fabrication of thinner
rings limits the resolution attainable by zone plates.
Zone plates offer superior spatial resolution at the expense of considerably reduced
flux, owing to their low diffraction efficiency (≈ 20%). Modern focusing systems employ serial zone plates which, when aligned correctly, increase the diffraction efficiency.
CRLs lie somewhere between the zone plates and KB mirrors as the entrance aperture
must be comparable to the hole radius, R, which must be relatively small to achieve
reasonable focal lengths. For X-ray images presented here, focusing was achieved by
the method available at a given beamline, given in Table 2.3

2.3.3

Silicon drift detectors

Silicon drift detectors (SDD) are energy resolving detectors that are well suited
for XRF experiments because of their high maximum count rate, energy resolution
(∼ 30 eV in modern SDD’s) capable of resolving different elements, can be run at
temperatures achieved by Peltier cooling, and their ability to subtend a relatively large
solid angle [117]. The SDDs role as a detector has been developed around a scheme
of sideways depletion, which was first proposed by Gatti and Rehak in 1984 [118].
Highly resistive n- type Si can be wholly depleted by contact with an n+ material
provided that the contact is positively biased with respect to p+ contacts. In the
depleted zones, the only free electrons will be a result of either radiation interacting
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Table 2.3.
Focusing method used at each beamline
Beamline

Focusing Method

Achieveable
Spot Size (µm)

ALS 10.3.2

KB Mirrors

3

2-ID-D

Zone Plate

0.15

2-ID-E

Zone Plate

0.25

8-BM

KB Mirrors

1.5 or 25

18-ID

KB Mirrors

5

18-ID

CRL

25 (h) × 2(v)

20-ID

KB Mirrors

7

21-ID

Zone Plate

0.03

26-ID

Zone Plate

0.04

with the Si wafer. The p+ contacts are arranged as a series of concentric circles whose
voltages vary such that electrons are pushed towards an n+ diode in the center of the
wafer [119]. The energy of the ionizing radiation can be determined by how many
electrons were freed into the conduction band. By amplifying the collected electrons
with a charge-sensitive amplifier, each event will correspond to a step in the recorded
signal - the amplitude of that step is directly proportional to the energy of the ionizing
photon, which allows energy resolution. This amplified signal is typically sent to a
digitizer and filtering/pulse picking electronics before ultimately being converted into
a list of energy-resolved photons.
There are several sources of spectral broadening and noise for SDDs to consider.
Most notably is the full with at half maximum (FWHM) associated the detectors
counting, which defines an intrinsic limitation of the resolution of a detector. Because
the processes governing energy loss in the signal are not strictly independent, the
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statistics are assumed to be a deviation from a Poisson distribution characterized by
the Fano factor F. Under this distribution, the maximum attainable resolution is [109]
√
∆EDet = 2.35 F E
(2.26)
where E is the energy of incident bombarding photon,  is the energy required to create
an electron-hole pair and 2.35 is a conversion factor between standard deviation and
FWHM for Poisson statistics. Thermally excited electrons being considered as signal
is another major source of background for SDDs, which is minimized by cooling the Si
element via the thermoelectric effect. Other sources of background, whose details are
beyond the scope of this discussion, are electronic readout noise (especially associated
with amplification), incomplete charge transfer as a result of trapping, and defects in
the geometry of the silicon wafer.
In addition to the noise and peak broadening associated with the detector, there
are several detector artifacts that must be considered when analyzing the spectra
produced from an XRF measurement. Pile-up peaks, for example, occur when two
separate photons are considered to be the same event that will have an effective energy
of the sum of the two photons. While many detector systems have filters in place
to detect and reject many pile-up events, inevitably some will be recorded. There
are software techniques to correct for pile-up peaks. Another important artifact to
consider is the Si escape peak. Si escape peaks occur when, instead of fully absorbing
the incident X-ray, the Si wafer itself fluoresces. The effect of a Si escape event is that
the observed peak is 1.74 keV (at the Si Kα line) lower than expected. This can also
be accounted for in software while analyzing the spectra. Dead time corrections must
also be taken into account when quantifying XRF experiments. Dead time refers
to the time when the detector is not counting incident photons because it is busy
recording, yet radiation is still incident on the detector freeing electrons. This can
easily be accounted for by scaling the recorded counts by the live time.
In practice, there are several software packages available for fitting XRF spectra
[120, 121] that take these issues into account. All work presented here was fit using
the MAPS software package [120].
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2.3.4

X-ray absorption near edge structure (XANES)

By taking small steps in incident energies through an element’s absorption edge,
one obtains a XANES (X-ray Absorption Near Edge Structure) spectrum. XANES
measurements provide an elementally specific means to probe local coordination environment and oxidation state. As thus, it has become an established technique in a
broad range of fields including environmental, biological [122], and toxicological [123]
communities. In it’s purest form, a XANES spectra are recorded by measuring the
number of photons passing through a sample as a function of incident energy near
the absorption edge. Above the edge, fewer photons will be transmitted through the
sample. In practice, recording the fluorescence that results from absorption enables
much more sensitive measurements.
X-ray absorption spectra can be split into three regions: pre-edge, the XANES
region (near the absorption edge), and the extended x-ray absorption fine structure
(XAFS) region (far beyond the edge). The energy of the absorption edge conveys
the oxidation state of the element; more oxidized compounds have higher absorption
energies. There are two interpretations of this edge shift. In one sense, core orbitals
in oxidized species provide less shielding giving the nucleus a higher effective charge.
From purely electrostatic considerations, then, it is sensible that the transition from p
type to s type orbitals is energetically taxed when moving against the gradient of the
higher effective charge. The oxidation sensitivity of XANES can also be considered
from a geometric point of view. For XANES measurements, we are considering a
transition between the core electrons (e.g. 1s for the K edge) to either continuum
or unoccupied orbitals near continuum. Since higher oxidation leads to shorter bond
lengths and the potential from the nucleus should behave as 1/r, the edge energy
must be higher for more oxidized species.
XANES data also provides information on the metal’s coordinating environment.
If we assume only dipole (E1) transitions are allowed, then a transition to 1s from
some metals valence d shell is forbidden. However, if the molecular d shell orbitals
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exhibit p type characteristics (p-d hybridization) then the transition may occur, giving
rise to a pre-edge. The pre-edge happens at a strictly lower energy than the K edge
because it arises from a transition to an orbital that lies below continuum. While
the edge energy is determined by the binding energy of the electron being sent to
continuum, the location is also sensitive to the absorption site’s binding energy. This
can also be resolved through electrostatic arguments. An oxidized absorption site will
have a higher effective charge as a result of weakened electronic shielding; consequently
the electrons will be more tightly bound, increasing the energy gap between the K
shell and continuum. The EXAFS region is not discussed here, but the curious reader
is referred to [124].

2.4

Immunohistochemistry: a (very) brief primer
Immunohistochemistry (IHC) is a means to detect antigens, often proteins, in

tissue sections. The labeling of specific antigens is possible due to antibody-antigen
binding specificity. An immunoglobulin G (IgG) antibody is depicted schematically in
Figure 2.6A. The antibody consists of a two identical large (heavy) and two identical
smaller (light) polypeptide chains. At the end of each chain is the hypervariable region, depicted in orange, which is specific to the target antigen. Only immunoglobulin
G (IgG) will be used in this work.
All of the immunostaining for this work is done with four basic incubations. First,
tissue is fixed using paraformaldehyde (PFA). PFA is a long polymer (approaching n =
100) of formaldehyde which interacts with antigens to form crosslinks, thus preserving
the structural integrity of the antigen. The aldehyde group can react with nitrogen
in protein backbones and form a rigid methylene (-CH2-) bridge between nearby
reactive atoms. It is thought, then, that the sample is preserved by the rigidity of
the matrix formed by methylene bridges. After fixation, the sample is incubated in a
solution of bovine serum albumin (BSA) and Triton X-100. Triton X-100 is a common
laboratory detergent used to permeabilize membranes. By extracting lipids, cell and
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Figure 2.6. A: Schematic of an antibody. B: Schematic for IHC. The
primary antibody binds to the desire antigen, and the secondary antibody binds to the primary antibody. Since the secondary antibody
is fluorescently labeled, protein expression can be probed using this
technique

organelle membranes become permeable to proteins and antibodies. Because the
extraction takes places in of polyoxyethylene moieties, there is no chemical specificity.
Thus, permabilization by Triton X-100 may give rise to false positives by removing
proteins from cells; the ensure specific staining a negative control stain should be
performed [125]. BSA is used as a blocking agent to prevent non-specific staining.
While purified antibodies show preferential affinity for their target epitope, it remains
a possibility that antibodies will bind to similar epitopes thereby producing falsepositive fluorescence while imaging a specimen. Blocking serves to occupy all epitope
binding sites with a protein that will a) still allow the higher affinity antibodies to
bind, b) react with many epitopes in such a way that it does not change the epitope
much, and c) does not react with the secondary antibody. By meeting these criteria,
significantly fewer secondary antibodies will bind with undesired epitopes while the
primary antibody may bind with its target and the fluorescent tag. After fixation and
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permeabilization/blocking, samples are ready for incubation in primary and secondary
antibodies (Figure 2.6B) and finally for imaging.
A table of antibodies used in this work is given in Table 2.4

2.5

Brain extraction and section preparation
This section outlines the standard protocol used throughout this work for animal

sacrifice and section preparation. Details of animal treatment, where applicable, is
given in the experimental description in later chapters. All experiments complied
with animal rights regulations and were approved by the Institutional Committee on
Animal Use at Purdue University and similar committees at collaborators’ institutions.
With the exception of the cuprizone study, animals were anesthetized with a
mixture of ketamine (75 mg/kg) and xylazine (10 mg/kg) via intraperitoneal (IP)
injection. Typically, the rodents are rendered unconscious within a few minutes as
assessed by a tail pinch or eye tap. If necessary, additional injections were delivered.
For the cuprizone study (Section 5.4), mice were anesthetized by inhalation of isoflurane. Once unresponsive, the iliac artery was severed and blood drained from the
animal. The brain stem was then severed and the skull peeled away allowing the
brain to be removed with a spatula onto a clean Kimwipe. After blotting the brain
on the Kimwipe to remove excess blood from the surface, the whole brain was snap
frozen in liquid nitrogen. Once frozen, the brain was placed on dry ice while other
rodents were sacrificed before being moved for storage at -80 ◦ C.
All tissue sections were cut on a Shandon FE/SE cryotome (Thermo-Fisher). The
night before sectioning, unsectioned brains are moved from -80 ◦ C storage to -20 ◦ C
and ultimately brought to -12 ◦ C in the cryotome chamber. Brains (or bilaterally
dissected brains) were mounted to the cryocasette using TissueTek Optimal Cutting
Temperature (OCT) medium such that the medium never came in contact with the
regions to be imaged. Sections were cut using a chilled BM-22 blade (Thermo Fisher)
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at ∼ 2◦ with respect to the sample head. To ensure correct sample alignment and
position, sections were stained with cresyl violet and compared to a reference atlas
(e.g. [126]). Samples 10-30 µm thick were taken on the following substrates:
• Prolene R 4 µm thick polypropylene: Compatible with XRF measurements.
Polypropylene film was secured to plastic frames. Polypropylene is free of metals
and shows no diffraction signal in the d = 10 − 120 Å range. It does, however,
exhibit a fiber diffraction pattern at d ≈ 4 Å.
• 6 µm thick Mylar: Compatible with XRF measurements. Mylar film was
secured to plastic frames. Mylar is free of metals and shows no diffraction
signal in the d = 10 − 120 Å range or in the d ≈ 4 Å range.
• Silicon nitride windows: 50 nm thick Si3 N4 windows. These are typically
not used because they are fragile and expensive. However, both nanoprobe
beamlines (21-ID and 26-ID at the Advanced Photon Source) have sample positioning systems that are designed around their use. Silicon nitride windows
are compatible with both XRF and diffraction measurements.
• Si wafers 100 µm thick Si wafers were used for experiments in Section 4.1.
These frames are designed to provide excellent thermal conductivity with the
coldstage on Linkam cryostages.
• Glass slides: Standard glass microscopy slides for samples. These are not
compatible with X-ray measurements but provide a convenient, flat substrate
for optical microscopy.
Once thawed onto a substrate, samples are stored on dry ice while other sections
are taken. Following a sectioning session, samples are stored at -80 ◦ C until use.
A map of typical sections taken is given in Figure 2.7.
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Figure 2.7. A. Sagittal section from a rat brain Lateral 1.9 mm. The
lines indicate the sections shown in B and C. B. Coronal rat brain
section at Bregma - 0.8 mm. C. Coronal rat brain section at Bregma
- 2.56 mm. Abbreviations are given in the list of abbreviations.

2.6

Statistical analysis
Throughout this work, except where noted, data are reported as the mean ±

standard deviation. For comparison of groups, one-way analysis of variance (ANOVA)
was used. Groups were considered statistically significant at the p < 0.05 level.

GFAP
Ki67
BrdU
Fzd9
UBQ
LAMP1

Glial Fibilary Acidic Protein

Ki67

Bromodeoxyuridine

Frizzled 9

Ubiquitin

Lysosomal-associated membrane protein 1

Marker for lysosomes

Marker for ubiquitin, which flags proteins for degredation

Nuclear marker for stem cells

Nuclear marker for cells that have been created after BrdU injection

Nuclear marker for cells not in the resting S-State of cell cycle

Cytoskeletal marker for astrocytes

Abbreviation Notes

Antibody

Table 2.4.
List of primary antibodies presented in this work.
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3. Localization of Cu-rich aggregates in the rodent brain
Conventional methods for metal quantitation in the brain by atomic absorption spectroscopy, mass spectrometry or utilization of radioactive copper isotopes such as 67Cu,
lack fine spatial resolution. A recent review of neuroimaging techniques, for instance,
listed laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) as
having spatial resolutions ranging between 5-150 µm [127]. While such imaging is
unquestionably valuable for brain research, it does not presently achieve resolutions
required to explore phenomena on the sub-micron scale for which XRF is well suited.
Secondary ion mass spectrometry (SIMS) has also proven to be a useful tool for biological imaging but has limitations related to a small probe volume. Numerous stains
for copper have the required resolution but fail to provide quantitative information.
Moreover, none of the conventional techniques can define the Cu oxidation state.
Development of fluorescent sensors to Cu+ is hindered by the properties of Cu+ as
a strong fluorescent quencher and the low stability of free Cu+ in water medium.
XRF imaging provides the sensitivity and spatial resolution necessary to reveal the
distribution of metals in tissues and single cell. Furthermore, co-localization of XRF
maps with histochemical markers allows for unambiguous determination of which cell
types or organelles Cu aggregates reside.
Taking advantage of the excellent spatial resolution afforded by XRF, the localization of Cu aggregates in the SVZ may be determined. First, it will be demonstrated
that elevated Cu in neurogenic areas is due to very intense, localized Cu aggregates
of about 1 µm in size. These aggregates present in the subventricular (SVZ) zone
of rats and mice. Furthermore, similar aggregates are demonstrated in the rostral
migratory stream (RMS) and dentate gyrus of rats, but not mice. While the origin
of this species discrepancy is unknown, it may be related to the ability of rats to produce more neurons and have them functionally integrated more readily. The SVZ is
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composed primarily of four cell types (Section 1.5), and it will be shown by combined
XRF and IHC that Cu aggregates reside specifically in type-B cells. Finally, seeking to determine if aggregates are present in autophagic processes, it is shown that
Cu aggregates do not reside in lysosomes and are not immunoreactive to ubiquitin.
As these represent the two major pathways of autophagy, the data suggest that Cu
aggregates play some role and are not merely awaiting degradation.

3.1

Cu-rich inclusions are found in cells in neuroproliferative zones
Previous reports have found the neurogenic periventricular regions [105, 128] and

dentate gyrus [104] of rodents to have elevated Cu. These studies, by LA-ICP-MS,
could not achieve the required spatial resolution to distinguish between elevated homogenous Cu distributions and discrete puncta. With submicron resolved XRF imaging, it is possible to resolve individual Cu granules, confirming that Cu in neurogenic
niches is present as inclusions. Table 3.3 summarizes where XRF microscopy has
determined Cu aggregates to be present. Both rats and mice exhibit Cu aggregates
in the subventricular zone. As neurogenic activity extends from the SVZ along the
rostral migratory stream (RMS) en route to the olfactory bulb (Figure 2.7), it was
of interest to determine if Cu-rich aggregates also exist along the RMS. The rodent
RMS has been reported to be supported by an astrocytic ribbon made of type-B
cells [129, 130]. If aggregate containing cells themselves migrate along the RMS, one
expects to find aggregates along the RMS. It was found that rats, but not mice, have
Cu aggregates along the RMS. While the cause of this difference is not yet clear, it
highlights the importance of species consideration when studying neurogenesis in the
SVZ and RMS. The final neurogenic niche – the dentate gyrus (DG) of the hippocampus which is much better characterized than the RMS – was also examined. Similar
to the RMS it is shown that rats but not mice have Cu aggregates. These results
suggest the role of Cu may be related to neuronal production and integration.
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3.1.1

Experimental details

The primary aim of this section is to demonstrate that previously reported elevated
Cu concentrations in neuroproliferative zones is due primarily to Cu inclusions, rather
than as a basal cellular Cu concentration. As such, it is a summary of a variety of
species imaged over several years. XRF imaging conditions are given in Appendix A
from sections prepared following protocol described in Section 2.5.
As the majority of Cu in the SVZ and RMS (for rats) lies in a single cell layer,
it can be difficult to objectively choose a region of interest with 25 µm resolution.
Concentrations in Table 3.2 are the result of analyzing 25 µm images (e.g. Figure
3.3A,B). To mitigate the influence of the experimenter’s choice, ROIs for analysis were
chosen as follows: a line was drawn to select either the SVZ or RMS. This line was
extended by 3 pixels on either side perpendicular to the line making the total ROI 7
pixels (175 µm) wide. It should noted that this will artificially lower the reported Cu
concentration. It is possible to use concentration thresholding to isolate Cu hotspots
within the wide region. However, the vast differences in Cu concentration between
rats and mice make that a complicated issue and unthresholded data serves for the
purposes of this discussion. The striatum and cortex are large, homogenous areas so
their mean concentration was determined by hand drawn ROI selection.
To supplement XRF images in the dentate gyrus, dark field micrographs of 3,3’diaminobenzidine (DAB) stained hippocampii are included (images provided by Dr.
John Young, Howard University). DAB is a compound that forms a dark precipitate
in the presence of peroxidase or pseudoperoxidase activity. DAB staining was done by
incubating sections in a DAB mixture (25 mg of DAB were added to 50 ml of 0.05 M
Tris buffer, pH 7.2, and then mixed with 1 ml of 3% H2 O2 ) for 30 minutes following
3×5-minute PBS rinses. DAB staining in the SVZ is presented and co-localized with
XRF maps in Section 4.3. It should be noted that only a subset of DAB+ granules
represent Cu-rich aggregates.
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3.1.2

The distribution of Cu aggregates in rats and mice in neuroproliferative zones

Figure 3.1 shows Cu XRF fluorescence maps recorded from rat brain sections. In
rat brain, Cu accumulations were detected along the ventricle walls, in the external
capsula, and in the septofimbrial nucleus and triangular nuclei. In particular, a
considerably elevated Cu content was noted along the lateral ventricle wall [128].
Similar distributions are observed in the SVZ of mice (Figure 3.3, Table 3.2).

A

cortex

B

cortex
cc

cc

HPCf

lv
lv
striatum

500 μm
low

high

500 μm

Figure 3.1. Cu XRF maps from coronal rat brain sections at Bregma
= -0.8 mm (A) and Bregma - 2.56 mm (B)
.
To determine if accumulations are intracellular, which the local fluctuations in
intensity suggest, brains were imaged with 300 nm resolution. XRF microscopy with
subcellular resolution on rodent brains revealed Cu accumulations in cells of the SVZ
(Figure 3.2). Additionally, XRF microscopy provides elemental markers of the cell
structures. For instance, cell nuclei were identified by increased phosphorous signals,
while sulfur and iron were distributed throughout the cytoplasm. Potassium was
concentrated inside the cell, thus helping to define the overall cell shape. XRF mi-
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Table 3.1.
Cu Concentrations of Cu-rich inclusions in the SVZ
Rodent

Area Number

[Cu] (mM)

Rat 1

1

237.62 ± 81.8

Rat 1

2

203.00 ± 91.2

Rat 2

1

313.16 ± 113.3

Rat 3

1

168.38 ± 62.9

Rat 3

2

240.77 ± 95.9

Rat 3

3

341.48 ± 135.3

Mouse 1

1

368.24 ± 228.1

Mouse 2

1

398.13 ± 173.1

croscopy clearly showed Cu rich accumulations up to 1 micron in size and with Cu
concentrations on the order of hundreds of mM (Table 3.1). Cu accumulations were
detected in close proximity to cell nucleus (as visualized by increased phosphorus signal) as well as at considerable (up to 5 µm) distances from the nucleus. Remarkably,
the detected Cu rich accumulations had low concentration of other metals such as Zn
and Fe (Figure 3.2). A lack of co-localization with Zn eliminates the possibility that
they originate from Cu/Zn superoxide dismutase 1. Co-localization of the Cu signal
with S was prominent in all positions of increased Cu content (Figure 3.2, Table 4.1).
This distribution was observed in both rats and mice.
Analysis of Cu in the SVZ and RMS of 12 week old Sprague–Dawley rats and CD1 mice (Table 3.2) reveal some striking differences. First, Cu concentrations in the
SVZ are nearly 2.5× higher for mice than rats. By contrast, the striatum and cortex
– regions where Cu-rich aggregates are not observed – are only 1.7× and 1.3× higher.
Secondly, in rats the RMS has a Cu level comparable to the SVZ and considerably
above the striatum and cortex, as is evident in XRF maps (Figure 3.3A). Mice, in
contrast, have a mean RMS Cu concentration well below that of the SVZ and show
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Figure 3.2. Cu inclusions in the SVZ. A. XRF microscopy in mouse
brain clearly demonstrates intracellular structures with dramatically
increased Cu content. The cell nucleus is identified by the increased
phosphorous signal, while sulfur is distributed throughout the cytoplasm. Potassium has much higher concentration inside the cell than
outside and, thus, helps to define the overall cell shape. B. XRF image of the SVZ. Elemental concentrations are in µg / cm2 in 10 µm
thick sections. The dashed line shows the ventricle wall with brain
tissue in the right low corner. From XRF imaging it is evident that
SVZ selectively accumulates Cu over other trace elements. C. XRF
rat brain recorded with increased resolution along the ventricle wall
showing that the Cu is also present in rats as intracellular aggregates.
Cu Kα fluorescence is shown in red while Compton scattering is in
cyan. The white dashed line indicates the ventricle wall. D Image
of the same section as (C) after XRF analysis at room temperature
stained with cresyl violet demonstrates tissue integrity after exposure
to X-rays.
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Table 3.2.
Copper concentrations in the SVZ and RMS
12 week Sprague–Dawley Rat

12 week CD-1 Mice

5

3

SVZ

8.58 ± 1.03

24.45 ± 1.21

RMS

7.82 ± 2.02

8.93 ± 0.60

Striatum

6.30 ± 1.52

10.81 ± 2.12

Cortex

6.00 ± 1.35

7.88 ± 0.18

n

no contrast between the cortex or striatum (Figure 3.3B). Higher magnification XRF
maps show that the rat RMS elevated Cu is due to Cu-rich aggregates (Figure 3.3C)
whereas mice do not exhibit any contrast along the RMS (Figure 3.3D).
Cu concentrations in the RMS have not been previously reported. Here it is
demonstrated by XRF microscopy that Cu concentrations in the RMS are comparable
to those of the SVZ (Table 5.3) for rats but not mice. At present, there is no firm
explanation for this. Cu that forms accumulations must arrive at the RMS either
through direct uptake or via formation in the SVZ followed by migration through the
RMS.1 In the case of the former, these results suggest that Cu uptake is fundamentally
different between mice and rats, at least in the RMS. As CTR1 and DMT1 are thought
to be the primary Cu transporters across brain barriers (Section 1.2), these would be
prime candidates. CTR1 is known to be expressed at both the blood-brain barrier and
blood-cerebrospinal fluid barrier whereas DMT1 is only suspected along the bloodbrain barrier [35]; it is possible that rat astrocytes have enhanced Cu uptake compared
to mice resulting in the RMS accumulations. The latter would suggest that cells in
rats and mice have very different migratory behavior along the RMS.
1

It is also possible cells in the mouse RMS have some ability to remove these accumulations that
rats do not possess. However, there is no clear mechanism for that.
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Figure 3.3. Cu XRF maps of A. rat sagittal section and B. mouse
sagittal section with 25 µm resolution. While Cu concentrations are
higher in the SVZ for mice, Cu aggregates do not exist along the
RMS. C. Cu XRF map of a rat RMS with 1.5 µm spatial resolution,
showing that Cu is present as aggregates in the RMS. D. Cu XRF
map of a mouse RMS with 10 µm resolution showing that there are
no Cu-rich aggregates along the mouse RMS. Display range is given
in µg/g in 30 µm sections.

In the dentate gyrus of the hippocampus, rats showed both DAB-staining cells
(Figure 3.4C) and Cu accumulations detected using X-ray microscopy (Figure 3.4D).
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Mice of all strains surveyed (Table 3.3) harbored no Cu-rich hippocampal accumulations and did not exhibit DAB+ staining (Figure 3.4A,B).
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Figure 3.4. Distribution of Cu aggregates in the hippocampus. A.
Dark field micrograph of a DAB-stained mouse section shows no
aggregates. B. X-ray fluorescence maps of a mouse hippocampus
also shows no Cu accumulations, confirming that the Cu aggregates
present in rats and in the SVZ of both species are not present. C.
Dark field micrograph of a DAB-stained rat section reveals positivelystained aggregates in the dentate gyrus. D. Similarly, elemental maps
show dense Cu-inclusions in dentate gyrus of the rat hippocampus.
Scale bars: 100 µm. Display ranges are in mM through a 10 µm thick
section.

As to the functional role of inclusions, one expects the species difference in Cu
aggregate presence to manifest itself somehow. One possible manifestation is that
mice show reduced hippocampal neurogenesis and circuital integration in comparison
with rats. For example, newly born neurons in the dentate gyrus are three-fold more
numerous in adult rats as compared to adult mice, and are ten times more likely to be
recruited into learning circuits [131]. A diminished number of neurogenic astrocytes
in mice, as well as reduced oxidative stress, may well be the explanation for the species
difference we observed. Other species differences in the rat and mouse hippocampus
have been reported. In the mouse, dentate gyrus neurons are immunoreactive for
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Table 3.3.
Species summary of Cu inclusions in Neuroproliferative Zones
Species

SVZ Cu Inclusions

RMS Cu Inclusions

DG Cu Inclusions

Sprague-Dawley Rat

Cu+

Cu+

Cu+

CD-1 Mouse

Cu+

Cu-

Cu-

C57BL/6J×SvImJ Mouse

Cu+

Cu-

Cu-

129S1/SvImJ Mouse

Cu+

Cu-

Cu-

calretinin, but in the human and rat, these neurons fail to stain for this calciumbinding protein [132, 133]. Also, cholecystokinin immunoreactivity can be found in
the mouse dentate gyrus, but not in the rat. Finally, dentate gyrus neurons of the
mouse fails to stain for calcitonin gene-related peptide, but those of the rat show
prominent staining [132].
The difference between rats and mice conveys that there may be critically different
mechanisms at play with regard to neurogenesis and/or migration. These differences
will be important to consider moving forward, especially as literature in the field often
lumps results from rats and mice together.

3.2

Cu-rich inclusions reside in glial-fibrillary acidic protein-positive (GFAP+)
cells
A critical step in determining the role of Cu aggregates is to determine in which

cell types they reside. The existence of these aggregates in a particular cell type
implicates a function that coincides with that cell type’s function; on the other hand,
the presence of aggregates in all cell types would suggest that inclusions have more
universal role in the region and may be spread through cell division. To that effect,
two attempts were made to determine the cell specificity of Cu-rich aggregates in
the SVZ. First, cells were labeled for glial fibrillary acidic protein (GFAP) using
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gold nanoparticles for XRF imaging. As gold is not present in detectable levels in
healthy brains, any detected gold must be a marker for GFAP. Co-localization of
GFAP and Cu aggregates demonstrates that Cu resides in GFAP+ cells. Secondly,
co-localization of optically detected GFAP Cu X-ray maps confirms that aggregates
reside in GFAP+ cells. It is demonstrated that Cu aggregates reside in GFAP+
cells. Furthermore, aggregates do not co-localize with Br fluorescence corresponding
to bromodeoxyuridine (BrdU) positive cells – cells that have been born or divided
following BrdU treatment – suggesting that the inclusions reside in slow-proliferating
type-B cells.

3.2.1

Experimental details

Male Sprague–Dawley rats (Harlan, Indianapolis, IN.) were purchased 7-8 weeks
old and were housed in a temperature-controlled, 12/12 light/dark room, and allowed
free access to pelleted rat chow (Purina rodent chow 5001, 13 ppm Cu content) and
distilled, deionized water. At the age of 12 weeks, the rats were sacrificed and sections
were taken following the procedure in Section 2.5.
For immunolabeling with GFAP, sections were thawed, fixed with 4% paraformaldehyde (PFA) in phosphate buffered saline for 30 minutes at room temperature (RT),
washed twice with PBS, treated for 1 hour at RT sequentially with: 1) blocking/
permeabilization solution: (2% (w/v) bovine serum albumin (BSA) / 0.2% (v/v)
Triton X-100 in PBS), 2) primary antibodies in PBS containing 2% BSA with 1:200
rabbit anti-GFAP (abcam ab15580)), 3) secondary antibodies in PBS containing 2%
BSA: either Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen A-11034)) at 1:1000
dilution for optical microscopy or Nanogold 1.4 nm anti-rabbit IgG Au nanoparticles
(Nanoprobes #2003) 1:120 dilution for XRF microscopy. Three, five minute washes
with PBS were performed after treatment with primary and secondary antibodies.
Sections on microscope slides were subjected to ProLong Gold antifade reagent before being covered with a coverslip. Slides were sealed and stored at 4◦ C. Sections
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for XRF were quickly rinsed with ultrapure water to remove excess P and Cl from
residual PBS.
BrdU, a cell proliferation specific marker, can be incorporated into the newly
synthesized DNA of replicating cells (during the S phase of cell cycle) in place of
thymidine. BrdU was dissolved in saline to final concentration 10 mg per 1 ml. The
solution of BrdU was prepared twice in a day and kept on ice. 2 rats 12 weeks old,
350 and 330 g, received 45 mg BrdU daily via five IP injections for 6 consecutive
days. Before sacrificing the rats were not injected for 24 hours.
XRF imaging was done at beamline 2-ID-D at the Advanced Photon Source with
an incident energy of 12.0 keV for Au-GFAP co-localization, 10.0 keV for optical
GFAP co-localization and 13.8 keV for BrdU detection. Au was quantified by L edge
fluorescence. The pixel size for co-localization experiments was 0.3 µm.

3.2.2

Results of GFAP/Cu aggregate co-localization

XRF-microscopy with subcellular resolution demonstrated that not all cells in
the SVZ contained the Cu enriched accumulations (Figure 3.5). This is due to the
heterogeneous cellular composition of the SVZ with four types of cells (Section 1.5):
ependymal, GFAP-expressing astrocytes - type B progenitors, type C transit amplifying cells and type A migrating neuroblasts, comprising about 95% of its cell
population [83, 85, 134]. Co-localization of Cu XRF with optical and XRF-IHC fluorescence of immunochemically stained glial fibrillary acidic protein (GFAP), a marker
of GFAP expressing astrocytes, demonstrated that Cu is preferentially localized in
the GFAP positive cells (Figure 3.5A,B). For Cu occurring in cell bodies we observed
prominent GFAP/Cu co-localization due to bright GFAP stain of the cell bodies.
Weaker GFAP staining of processes also shows co-localization with Cu when GFAP
is visualized at decreased dark level. These results are in agreement with Cu / P distributions showing Cu accumulations at significant distances from cell nucleus (Figure
3.5A,B).
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Figure 3.5. A. Co-localization of optical fluorescence of immunochemically stained GFAP (green) and X-ray fluorescence from Cu (red).
The white dashed line indicates the ventricle wall. B. Subcellular colocalization of Cu with GFAP as visualized by immunostaining with
gold nanoparticles as a secondary antibody. C. Left: Schematic of the
cellular architecture of the SVZ. Progenitor cells (A-C) in the SVZ lie
adjacent to the ependymal cell (E) layer lining the lateral ventricles.
Right: XRF image of cells located in the SVZ of a Sprague-Dawley rat
treated with BrdU a marker of actively dividing cells. BrdU identifies
type A cells - migrating neuroblasts and type C cells - transit amplifying cells. Co-localization of Br and phosphorus X-ray fluorescence
signals shows actively dividing cells (dashed circles). Areas occupied
by dividing cells have a diminished number of Cu-accumulations. The
black arrows indicate the ventricle wall.
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Injection of rats with the proliferation marker BrdU allowed us to identify actively
dividing cells of type A and C (Figure 3.5C). In the brains of these rats, XRF measurements above the energy of the Br K edge detected the distribution of Br, while
measurements in control rats did not detect any Br signal. Selective visualization
of nuclei with Br enrichment was done by co-localization of Br and phosphorus signals (Figure 3.5C). Moreover, the cells with Br-enriched nucleus were smaller than
the others. This is in agreement with earlier studies showing that A-type cells are
smaller in size (about 8 µm) than those of the B- or C-type [83]. A-type cells are
also elongated along the direction of their migration along the ventricle wall (this direction is perpendicular to the plane of the image). While areas occupied by actively
dividing cells were mostly free from Cu accumulations, the cells surrounding them
showed Cu signals. It is known that type B progenitors surround actively dividing
cells of the SVZ (Figure 3.5C). These data thus support the notion that Cu primarily
accumulates in type B progenitors.
The exclusivity of Cu inclusions to astrocytes may be elucidating for its transport
mechanism into the brain. Like any mammalian cells, astrocytes uptake Cu into the
cytoplasm by copper transporter 1 (Ctr1). Ctr1 passes Cu to Cu chaperones, which
mediate the intracellular transport of Cu to cuproproteins via mechanisms utilizing
direct protein-protein interaction. Possible pathways for the Cu transport into the
astrocytes include Cu absorption either from the blood or the cerebrospinal fluid
(CSF). The BBB is partially lost on the surface of blood capillaries in the SVZ [135]
which can explain highest Cu accumulations detected in astrocytes positioned close
to the ventricle wall. The choroid plexus, a tissue in brain ventricles adjunct to the
SVZ, transports Cu and other metals between the blood and the CSF [136]. The CSF
is separated from the cells of the SVZ by only one layer of ependymal cells, which do
not form tight junctions. Some of the type B progenitors retain direct exposure to the
surface of the ventricle wall even in adults [48]. Thus, astrocytes have preferential (as
compared to neurons) access to the interstitial fluids as well as the CSF, in part due
to their perivascular endfeet. Observation of the extensive Cu accumulations in the
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astrocytes of the SVZ and partially in the ependymal cells might lead to the idea that
cells in this part of the brain function as an additional barrier between systemic fluids
and brain tissues (at least in terms of Cu transport). In such a case, accumulation
of Cu can be envisioned as a result of Cu retention at this barrier. However, it is
an unlikely function and that the astrocytes are rather balancing the Cu content in
the brain to meet the brains Cu needs than simply achieving Cu detoxification. In
support of such a view speaks the observation that the local Cu concentration in the
astrocytes is several orders of magnitude higher than those in the blood and CSF (e.g.
Table 5.1) which would imply a facilitated Cu uptake and retention. Moreover, the
concentrations of other possibly toxic metals such as Zn, Mn and Fe are not increased
in these cells as compared with brain cells at other locations, showing that other
metal ions are not accumulated at this potential barrier. This therefore implies that
astrocytes are uniquely capable of absorbing and retaining Cu ions. The ability of
astrocytes to retain Cu might also relate to the fact that these cells do not express
the ATP7B Cu transporter responsible for Cu export from the cell [137].

3.3

Cu-rich inclusions are not found in lysosomes or ubiquitinated
One hypothesis for the origin of these accumulations is that they are vestiges of

some other cellular process. If this were the case, it is reasonable to speculate that they
will be deteriorated at some point. There are two major cellular autophagic pathways.
Lysosomes are the workhorse of macroautophagy giving rise to the degradation of the
autophagosome it fuses with and its contents. More recently, attention has been given
to proteosomal degradation, particularly the ubiquitin-proteosome system (UPS, see
[138] for a review). To determine if accumulations were involved in a derogatory
pathway, co-localization experiments were carried out for Cu accumulations against
lysosomal-associated membrane protein 1 (LAMP1) and ubiquitin (UBQ).
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3.3.1

Experimental description

LAMP1 staining was done on a section from a 9 week old 129/SvImJ mouse and
UBQ staining on a 12 week old Sprague–Dawley rat. Sections were prepared according
to the protocol in section 2.5. For immunolabeling with LAMP1/UBQ, sections were
thawed, fixed with 4% paraformaldehyde (PFA) in phosphate buffered saline for 5
minutes at room temperature (RT), washed three times with PBS, treated for 2 hour
at RT sequentially with: 1) blocking/permeabilization solution: (2% (w/v) bovine
serum albumin (BSA)/0.2% (v/v) Triton X-100 in PBS), 2) primary antibodies in
PBS containing 2% BSA with either 1:200 rabbit anti-LAMP1 (abcam ab24170) or
1:50 rabbit anti-ubiquitin (abcam ab7780), 3) secondary antibodies in PBS containing
2% BSA: either Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen A-11034)) at 1:1000
dilution for optical microscopy or Nanogold 1.4nm anti-rabbit IgG Au nanoparticles
(Nanoprobes #2003) 1:120 dilution for XRF microscopy. Three, five minute washes
with PBS were performed after treatment with primary and secondary antibodies.
Sections on microscope slides were subjected to ProLong Gold antifade reagent before
being covered with a coverslip. Slides were sealed and stored at 4 ◦ C. Sections for
XRF were quickly rinsed with ultrapure water to remove excess P and Cl for PBS.
XRF imaging was carried out at beamline 2-ID-D (LAMP1) or 2-ID-E (UBQ) of
the Advanced Photon Source at an energy of 13 keV and a pixel size of 0.3 µm. Au
was detected by its L fluorescence.

3.3.2

Results of Cu-autophagic marker co-localization

Figure 3.6 shows immunostaining for the autophagic markers. Au labeled XRF
maps are shown on the right (Figures 3.6 B,D) and optical stains of comparable
sections are shown on the left (3.6 A,C) for comparison. It is clear that Cu inclusions
do not co-localize with lysosomes (via LAMP1 staining) and are not ubiquitinated,
which would be required for proteosomal recognition. These data suggest that Cu
aggregates are not involved in an autophagic process.
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Figure 3.6. Co-localization of Cu inclusions with lysosomes (LAMP1)
and ubiquitin (UBQ). A. Optical micrograph of LAMP1 staining
showing that LAMP1 stains small puncta that reside mostly in cells,
including GFAP+ astrocytes. B. XRF co-localization of Cu (green), S
(red), and Au-labeled LAMP1 (blue) showing that Cu does not reside
in lysosomes in the SVZ. C. Optical micrograph of ubiquitin staining
in the SVZ. Ubiquitin also forms small puncta that reside in cells. D.
XRF co-localization of Cu (green), S (red), and Au-labeled ubiquitin
(blue). These data show that Cu inclusions are not ubiquitinated.
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The non-involvement in autophagy is elucidating for the role of the Cu aggregates
in the cell. Firstly, it dismisses the possibility that the aggregates are a part of
aggresomes. An aggresome is a pericentrosomal, microtubule-dependent collection of
misfolded proteins flagged located [139, 140]. If Cu bodies were active in the UPS,
they would be immunoreactive to ubiquitin [141], which they are not (Figure 3.6D).
It will be shown in Section 5.1 that Cu aggregates become more numerous with
age. It is possible that the aggregates, in part, permit a mechanism of toxicity of
these inclusions at advanced age. In human embryonic kidney cells, for instance,
the presence of protein aggregates has been shown to compromise the UPS, either
through interaction with the proteosome itself or an auxiliary protein [142]. This leads
to a feedback loop in which individual proteins cannot be degraded quickly enough
and thus can form aggregates, the product which may not be immunologically active
for ubiquitin. While cells are prone to aggregation when treated with proteosome
inhibitor [143–145], cultured astrocytes in particular remain resilient due to their
ability to upregulate macroautophagy under proteosomal stress [146]. While moreactive macroautophagy protects cultured astrocytes, the in vivo fact is that advanced
age comes with diminished ability to carry out macroautophagy [147]. With an
impaired UPS and macroautophagy, older brains will be unable to correctly handle
misfolded proteins, which may ultimately lead to neurodegeneration.
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4. The composition of Cu-rich aggregates in the brain
Just as knowledge of where aggregates are located in the brain is critical, so too is
characterization of the composition of aggregates. Unbound Cu is cytotoxic as it
induces an avalanche of oxidative species that can lead to cell death. As such, it
is expected that hundred millimolar Cu aggregates will be bound in some protein
environment. To ascertain the traits of the binding environment, X-ray absorption
near edge structure (XANES) spectra were recorded directly from tissue. Obtained
spectra indicate that Cu is bound as Cu+ and is present in a Cux Sy multimetallic
cluster. Consistently, elemental analysis from XRF imaging with 30 nm resolution
demonstrates that Cu and S consistently co-localize with a molar ratio [S]/[Cu] =
1.66 ± 0.07. Furthermore, Fe and Cu are shown to form separate, peroxidase (or
pseudoperoxidase) activity exhibiting aggregates in the SVZ, which clarifies previous
work characterizing Gomori-positive aggregates. These results are consistent with
assignment of metallothionein as the via binding protein, but are not sufficient to
unambiguously determine the protein. Finally, considering many metal containing
aggregates form via a tau-facilitated method, X-ray diffraction is recorded directly
from Cu aggregates. It is shown that while aggregates exhibit Bragg peaks, they do
not exhibit the hallmark cross-β motif of other metal aggregates and so there may be
a new metal-related aggregation mechanism involved in aggregates’ formation.

4.1

Cu in aggregates is present as Cu(I)
Determining the oxidation state and coordinating environment of Cu in Cu aggre-

gates is critical to assigning a binding protein and elucidating their function. X-ray
absorption near-edge structure (XANES) in uniquely sensitive to metal oxidation
states and can furthermore be combined with microbeam imaging to ensure that Cu
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inclusions are measured instead of bulk brain Cu oxidation state. Cu aggregates from
thin (10-30 µm) brain sections were located with XRF microscopy and subsequently
probed with XANES measurements. These measurements reveal that Cu is present
in inclusion as Cu+ and as a Cux Sy multimetallic cluster.

4.1.1

Experimental description

Male Sprague–Dawley rats (Harlan, Indianapolis, IN) were purchased 7-8 weeks
old and were housed in a temperature-controlled, 12/12 light/dark room, and allowed
free access to pelleted rat chow (Purina rodent chow 5001, 13 ppm Cu content) and
distilled, deionized water and sacrificed at 12 weeks old. Sections at Bregma - 0.8 mm
were thawed onto 100 µm thick Si wafers and stored at -80 ◦ C until measurement as
described in Section 2.5.
For recording XANES directly from tissue, the sample must be kept very cold
to mitigate X-ray induced damage. To achieve this, a Linkam cryostage with a programmable temperature controller unit was mounted on the motorized stage at ALS
beamline 10.3.2 [148] and set to 80 K. Measurements were taken with a beam size
of 3 µm × 3 µm. As Cu inclusions constitute the majority of Cu in any individual
sampling voxel, it is assumed that recorded XANES reflects the oxidation and coordination state of aggregated Cu. Brain samples on 100 µm thick Si wafers, designed
for optimal thermal conductivity and tight contact with the silver cold block of the
cryostage, were placed on the cryostage via the sample port to prevent thawing. For
energy calibration of the Cu K-edge XANES, Cu foil was used with E0 = 8980 eV,
while internal scan-to-scan calibration was done using a monochromator glitch.
To compare recorded XANES from brain tissue with Cu-metallothionein, a suitable reference compound for Cux Sy compounds, Cu6 −metallothionein(II I) was prepared as follows [149]. Apo-Metallothionein (1A/2B mixture) was purchased from
Bestenbalt LLC (#031-2000) and dissolved to 1.6 mM in Tris-HCl buffer, pH 7.8.
To reduce oxidized apo-MT, dithiothreitol (DTT) was added at a concentration of
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48 mM (ratio DTT:MT = 30) and the mixture was incubated for 1 hour at RT. To
remove excess DTT, 100 µL of apo-MT and DTT mixture was loaded into a small
G-25 sephadex column, equilibrated with 0.01 HCl, and 1.3 ml of reduced apo-MT
was collected (final concentration ≈ 0.12 mM). CuCl at 10 mM was prepared in a
solution of 0.1N HCl and 4% NaCl and added to reduced apo-MT at ratio 6:1. The
mixture was incubated for 30 minutes at RT. After incubation, pH was adjusted with
Tris/HCl to pH 7.8. Cu+ -bound MT was concentrated using an Amicon Ultra-4,
PLBC Ultracel-3 Membrane, 3 kDa centrifugal filter unit (Millipore, UFC800324) up
to ≈ 3 mM. Holders for XAS were filled with the concentrated sample and placed
immediately in a -80 ◦ C freezer.

4.1.2

Results of Cu-XANES in the rat SVZ

Information on the copper’s oxidation state and ligand environment is critical
to elucidate the mode of its intracellular binding and its biological role in the cell.
Cu+ ions at the Cu K-edge are known to exhibit an intense feature at ∼8983 eV
corresponding to an electric dipole-allowed 1s-to-4p transition. The intensity of this
transition is sensitive to the occupancy of the Cu 4p orbitals which differs according to
the coordination (i.e. diagonal, trigonal, tetragonal, etc.). The shape and intensity of
this feature can be used to determine the coordination environment of the Cu+ site in
proteins [150, 151]. XANES on the intracellular Cu rich accumulations was recorded
at low (80 K) temperature ensuring non-damaging conditions (Figure 4.1). Spectra
obtained from different Cu enriched accumulations were the same within signal-tonoise (Figure 4.1C). This demonstrated that Cu inside different accumulations has the
same binding environment. The energy of the Cu K-edge unambiguously identified
the Cu oxidation state as Cu+ . A comparison of the obtained XANES spectrum with
spectra of model Cu compounds and Cu bound proteins available in the literature
showed that it was characteristic for the cuprous-thiolate multimetallic cluster and
closely resembled the spectra published for a variety of Cu-metallothioneins. The
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work of Pickering et al. [151] illustrates that details of Cu XANES spectra are different
for different proteins containing cuprous-thiolate multimetallic clusters. This is not
surprising as the electronic structure of the metal clusters in proteins is known to be
affected by the protein environment. In Cu XANES the number of transitions and
their relative intensities are sensitive to the electronic structure of the Cux Sy cluster.
Assignment to cuprous-thiolate multimetallic cluster agrees with the identification
of a predominantly sulfur coordination environment from co-localization of the Cu
and S signals from XRF microscopy (Section 4.2). Comparison of the Cu XANES
spectra from the intracellular compartments with the spectrum of Cu-MT prepared
from rabbit apo-metallothionein and recorded at the same experimental conditions
demonstrated a high degree of similarity (Figure 4.1D).
Taking into account how dangerous elevated Cu levels can be better understanding
of Cu-binding/sequestration in astrocytes is critical. Intracellular Cu K-edge XANES
measurements are instrumental in this regard. The high degree of similarity between
the XANES spectra of intracellular Cu in astrocytes and those of prepared Cu-MT
suggests that Cu is bound to MT or protein providing similar Cu binding environment
with the formation of multimetallic Cux Sy cluster. One of the hallmarks of a multimetallic Cu+ −S cluster XANES spectrum a monotonic increase of absorbance with
energy near the Cu K edge (8979 eV) due to the Cu-Cu binding. There are numerous
examples in the literature [152,153] which compare Cu-S clusters to model compounds
with only one Cu that exhibit decreased absorbance immediately following the edge.
Since spectra from both tissue and Cu-MT exhibit increasing absorbance at the edge,
it is concluded that the Cu is bound in the form of multimetallic cluster. Furthermore, Table 4.1 illustrate that the [S]/[Cu] ratio is comparable to the one expected for
Cu-MT. High local Cu concentrations (100-500 mM) indicates potential aggregates
and MT has been shown to form aggregates with Cu in pathological conditions [154].
In the brain, astrocytes are the principal source of MT I and II, although other cell
types also express MT I and II [155, 156]. Astrocytes of the SVZ show intense MT I,
II expression detected by in situ hybridization and immunohistochemistry [157, 158].
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Tissue
Metallothionein

Figure 4.1. A. Schematic diagram of coronal section located at approximately Bregma -0.8 mm. The red box indicates the approximate area of the XRF image. B. XRF image of copper distribution
demonstrates that Cu enrichment is localized to a thin layer along
the lateral ventricle wall. XANES measurements (C) were taken on
Cu accumulations, indicated by arrows. Spectra obtained from different Cu-accumulations are the same within signal-to-noise. The red
line is the average of all XANES measurements taken on this sample.
D. Intracellular Cu K-edge XANES spectrum at low temperature on
the Cu accumulations in a rodent brain (red) recorded at the same
experimental conditions as the spectrum of Cu-MT prepared from
rabbit apo-MT (blue). The high degree of similarity indicates that
Cu is present in brain cells in the form of a Cu+ -thiolate multimetallic
cluster and suggests that MT serves as a Cu binding protein.

Metallothionein, a ubiquitously occurring low molecular weight cysteine-rich protein,
is involved in numerous physiological processes including metal ion homeostasis, ox-
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idative stress defense and stimulation of neurite growth [159]. The role of the Cu-MT
complex in detoxification of intracellular copper is well established. For instance,
one of the therapies received by Wilsons disease patients, whose organisms cannot
effectively excrete Cu due to a genetic defect in the ATP7B Cu-transporter, induces
metallothionein to facilitate Cu-binding in hepatocytes. While we have not confirmed
that Cu accumulations are bound to MT, such an assignment is consistent with current literature. The role of metallothionein in Cu-rich aggregates is further studied
with MT knockout mice in Section 5.2

4.2

Nanoprobe XRF analysis of Cu inclusions
To probe the elemental composition of Cu aggregates, it is necessary to have an

imaging technique with finer spatial resolution than the size of the particle under
analysis. Microprobes (∼300 nm spot size) technically achieve this resolution for 1
µm diameter particles, but render the particle only a few pixels, making quantitative
analysis difficult. Recently, the construction and commissioning of nanoprobes –
beamlines with spot sizes smaller than 50 nm – has enabled these particles to be
analyzed with adequate spatial resolution. Currently, there are two such beamlines:
the Nanoprobe [160] and the Bionanoprobe [161] at the Advanced Photon Source.
Both of these beamlines were employed to analyze the ultrastructure of Cu inclusions.
It is shown that 1) Cu aggregates are likely spheroids, 2) Cu aggregates rarely colocalize with other metals (e.g. Fe, Zn, Mn), and 3) Cu aggregates consistently
co-localize with S at a [S]/[Cu] molar ratio consistent with metallothionein being the
binding protein.

4.2.1

Experimental description

Male 129S1/SvImJ were purchased from Jackson Labs and sacrificed at 9 weeks
old. Mice were chosen for nanoprobe studies as they typically have higher Cu concentrations along the ventricle than rats (Figure 3.3) which makes it easier to find
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aggregates to scan. Following the sample preparation protocol detailed in Section
2.5, 5 µm thick coronal sections at Bregma - 0.8 mm were thawed onto 50 nm thick
silicon nitride windows that are compatible with both nanoprobes’ sample positioning
systems. Samples were stored at -80 ◦ C until right before measurements. As both
nanoprobe beamlines use vacuum sample environments, samples were dehydrated before loading onto the beamline. Both beamlines were run with an incident energy of
10 keV and had spot sizes of 30 nm (Nanoprobe, 26-ID) or 40 nm (Bionanoprobe,
21-ID).

4.2.2

Results of nanoprobe analysis of Cu inclusions

Often, Cu aggregates imaged with <50 nm resolution appear as spheroid objects (e.g. Figure 4.3D). Since X-ray fluorescence is emitted through the thickness of
the entire sample, the recorded maps are two-dimensional projections of the threedimensional tissue section, and so overlapping spheroids may appear as clusters. Assuming each Cu accumulation is a spheroid-like object, it is possible to deconvolute
the separate inclusions. An example is shown (Figure 4.2A) where three spheres are
present fitting the intensities of appropriately selected lineplots to a double Gaussian
model (Figure 4.2D) confirms that (R2 > 0.98). It is worth noting that there may
be some discrepancy in reported numbers from different lines as the accumulations
are not perfect spheres and thus the reported values are sensitive to the choice of line.
A survey of Cu inclusions in the subventricular zone finds the mean concentration
to be 23.60±2.02 µg/g (in a 5 µm section) and the average size of aggregates to be
0.30 ± 0.02 µm (FWHM based on Gaussian fitting.)
Co-localization of the Cu signal with S was prominent in all positions of increased
Cu content (Figure 4.2). Linear fits of correlation curves (Figure 4.2B) allowed us to
estimate the S/Cu molar ratios in the range of 1.1 to 1.7 (Table 4.1). Increased spatial
resolution and sample thicknesses allow a more accurate determination of [S]/[Cu].
Since fluorescence is recorded from the entire sample thickness, all that can be in-
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Figure 4.2. Nanoprobe analysis of Cu inclusions. A. A representative
Cu hotspot imaged with 30 × 30 nm2 pixel size. It is evident that Cu
and S co-localize strongly and that accumulations are intracellular.
Units are µg/cm2 in a 5 µm thick section. B. S/Cu molar ratio only
from pixels in the hotspot. Fitting the data to a linear fit yields a
S/Cu ratio consistent with assignment of MT(1,2) and/or MT3 (see
table 1.) C. A close-up on the Cu hotspot featured in A. The three
lines correspond to the Cu intensity profiles drawn in D. Yellow dots
identify the peak locations when fit to a Gaussian distribution. D.
Cu intensity profiles corresponding to the green (top), red (middle)
and magenta (bottom) lines in C. All three lines are well described by
fits to two Gaussians, indicating that Cu hotspots are spheroid-like
objects with diameters of around 1 µm.
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Table 4.1.
S/Cu molar ratios at different imaging conditions
Sample Set

Spatial Res- Sample

[S]/[Cu]

olution

Thickness

Sprague-Dawley Rats

300 nm

10 µm

1.12 ± 0.07

129S1/SvImJ Mice (MTWT)

300 nm

10 µm

1.18 ± 0.05

129S1/SvImJ Mice (MTWT)

30 nm

5 µm

1.66 ± 0.07

Cu12 -MT(1,2)

-

-

1.58 - 1.75

ferred is the mean concentration. Since XRF maps of aggregates demonstrate that
aggregates are around 1 µm in diameter and very concentrated, the remaining sample
lowers the average intensity; there are 9 µm of baseline intensity for microprobe data
but only 4 µm for 5 µm thick sections, meaning that [S]/[Cu] from thinner sections
should not only be higher, but also more accurate.
While Cu inclusions do not co-localize with other metals, it should be noted that
there also exists a separate class of Fe-rich inclusions in the SVZ. To quantitatively
determine if Fe and Cu co-localize in individual clusters, images with 30 or 40 nm
resolution were thresholded at 17.9 mM for Fe or 31.5 mM for Cu (corresponding to
0.5 and 1.0 µg cm−2 in 5 µm thick sections). Particles were then defined by requiring
at least one of the surrounding eight pixels to be above the threshold. In other words,
if two connected sets of pixels have no connecting pixels they are treated as two
separate clusters. To reduce any fluctuations due to noise, only clusters with 5 or
more pixels were considered in analysis. For clarity, an example of particle detection is
shown in Fig. 4.3B where arrows indicate particles used for analysis. For each cluster,
Pearsons correlation coefficient, r, was computed using all pixels in the cluster. A
total of n = 17 Cu clusters and n = 22 Fe clusters were included in analysis from
two mice. A summary of correlation coefficients is found in Figure 4.3C. In Cu-rich
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clusters, the average correlation was found to be r = 0.03 with a median of r = 0.03.
In Fe rich clusters (n = 22 identified clusters), the mean was r = 0.01 with a median
r = 0.06. These data show that Fe and Cu do not co-localize in unstained sections,
with rare exception (e.g. Figure 4.3D). The implications of this are discussed in
Section 4.3.
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Figure 4.3. A. XRF map of Fe at 30 nm resolution from an unstained
mouse section. In untreated sections, Cu and Fe aggregates tend not
co-localize. Scale bar: 500 nm B. Demonstration of particle detection
on the Fe map in A. Clusters with arrows, which have 5 or more
pixels, are used for co-localization analysis. Scale bar: 500 nm. C.
Co-localization statistics showing Pearsons correlation coefficient for
Cu-rich clusters (left) and Fe-rich clusters (right). A boxplot showing
the median, 25th percentile, 75th percentile and extremal values is
given along with a scatter plot for individual clusters imaged with
30 nm or 40 nm resolution is shown. D. Co-localization of Cu, Fe, and
P with 40 nm resolution demonstrating a case of Fe-Cu co-localization
in the left cluster (r = 0.49). Display ranges are given in mM through
a 5 µm thick section.
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4.3

Iron and Cu separately form the basis for pseudoperoxidase activity
in the subventricular zone
Prior to high-resolution elemental imaging, metal-rich inclusions in neurogenic

niches were studied by histology, which is not strictly element-specific. Dating back
to the early 1970’s, it was recognized that many mammals (including humans [162])
posses a subpopulation of glial cells that contain peroxidase activity exhibiting granules [163]. These granules were characterized by their positive staining for Gomori’s
chrome aluminum hematoxylin, their positive 3-3’-diaminobenzidine (DAB) staining
for peroxidase or pseudoperoxidase activity, and orange-red autofluorescence [164].
These granules have come to be known as Gomori-positive (GP) inclusions. Suspecting a porphyrin binding environment causing autofluorescence, researchers in the
early 1990’s tried to determine the metal basis, if any, for this peroxidase activity.
Conflicting reports were published arguing that Cu [165] and Fe [166] give rise to
peroxidase activity. While Section 4.2 details that Cu and Fe aggregates exist separately in the SVZ, it did not characterize peroxidase activity in the region. The
present experiment aims to determine, by DAB-XRF co-localization, if the Cu inclusions reported by XRF are homologous to the pseudoperoxidase granules described
previously. It is shown that both Cu and Fe can produce DAB+ staining.

4.3.1

Experimental Details

A male C57BL/6 mouse (15 weeks old) was sacrificed and sections were taken
at Lateral ∼1.9 mm according to the procedure outlined in Section 2.5. For XRFDAB co-localization, a 30 µm section was used. Prior to imaging, the section was
brought to room temperature and stained for peroxidase or pseudoperoxidase activity.
To stain, the sample was incubated in 0.05% DAB in DAB buffer (0.015% H2 O2 in
phosphate buffered saline (PBS)) for 30 minutes. The sample was then incubated for
5 minutes in PBS three times to stop DAB precipitation. To remove excess elements
from PBS, the sample was quickly rinsed twice with ultrapure water. The sample
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was imaged with an optical microscope both prior to and immediately after X-ray
imaging for co-localization with X-ray maps.
X-ray maps were recorded at beamline 2-ID-D at the Advanced Photon Source
with a beam size of 250×250 nm2 and an incident flux of 4×109 photons per second
at 10 keV. Co-localization was carried out using the landmark correspondence [167]
by transforming the optical image to match features on the X-ray maps allowing
translation, isotropic scaling, and rotations (i.e. under a similarity transform).

4.3.2

Results of DAB-XRF co-localization

DAB and XRF maps of the same region co-localized are shown in Figure 4.4.
It should be noted that the staining process likely modified the metal distribution.
DAB+ granules were observed in several situations with respect to metal presence.
Some granules are observed in the absence of metal accumulations. Such granules
would have either a non-metal or a very dilute metal origin for peroxidase or pseudo
peroxidase activity. It is also possible that DAB+ stains that do not co-localize with
metal were a result of metals that were washed away during the staining process.
More commonly in the SVZ, DAB+ granules do co-localize with Cu, Fe, or Cu and
Fe puncta, rendering the metal accumulation a likely source of pseudo peroxidase
activity.
This experiment was designed to resolve conflicting claims in the literature that
peroxidase activity exhibiting (DAB+) granules derive from Fe complexed with porphyrins [166, 168, 169] while other reports demonstrate that accumulations are Cu
rich [165, 170] as measured by energy dispersive spectroscopy (EDS). Similarly, our
XRF data with 30-40 nm resolution characterizing untreated mice show Cu-rich aggregates and a separate set of Fe-rich aggregates (Figure 4.3). Analysis of DAB-XRF
co-localization compliments nanoprobe analysis in demonstrating that Cu aggregates
do not contain Fe and vice-versa. All of the spherical metal accumulations observed,
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Figure 4.4. DAB-XRF Co-localization. A. Low-magnification micrograph of the DAB-stained section. The arrow points to the rostral
corner of the ventricle, which was imaged. Scale bar: 100 µm. B.
Untransformed optical micrograph of the rostral corner. The dashed
line indicates the ventricle wall and the box outlines the area imaged
with X-ray microscopy. Scale bar: 10 µm. C. Co-localization of Cu,
Fe, and optical images showing that DAB+ granules often, but not
always, co-localize with metal aggregates. Note that the optical image
has been transformed as described in Section 4.3.1. Scale bar: 5 µm.

which was the shape reported as GP inclusions, were primarily composed of Cu and
do not co-localize with Fe.
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As for the binding protein, Fe aggregates of both porphyrin and non-porphyrin Fe
coordination have been proposed. For instance, similar Fe aggregates were recently
examined in neurons and were suspected to be siderosomes while hold Fe as ferric
hydroxide [171]; ferritin has also been proposed [166]. As both heme and non-heme Fe
are capable non-enzymatic peroxidase activity [172,173], the present data is unable to
determine a source. With respect to the source of Cu DAB staining, previous work has
shown that Cu is present as Cu+ and as a Cux Sy cluster with a [S]/[Cu] ratio consistent
with that of Cu-metallothionein (Section 3.1, Table 4.1). As metallothionein has an
established role in hydrogen peroxide protection [174], it seems plausible that an
aggregate containing Cu-metallothionein or a similar Cu-protein cluster could exhibit
peroxidase activity.

4.4

X-ray diffraction of aggregates reveals that aggregates have periodic
structure
As discussed in Section 1.3, metal-containing protein aggregates have been re-

ported before in the context of disease. While the Cu aggregates under discussion are
present in healthy rats and mice, there is a distinct possibility that these aggregates
and neurological plaques (e.g. amyloid plaques) are formed by similar mechanisms.
The structural hallmark of other metal-containing aggregates is cross-β sheet formation, which exhibits fibrillar diffraction at 4.2 Å [175]. The protein tau, which
normally is involved with microtubule stabilization, is thought to facilitate cross-β
sheet formation following hyperphosphorylation [176]. If Cu aggregates are formed
by the same tau-mediated pathway as other cross-β aggregates, then one expects to
observe fiber diffraction at 4.2 Å from Cu aggregates as well. This experiment was
designed to determine if Cu aggregates will exhibit any diffraction; in particular observation of a fiber diffraction ring at 4.2 Å would suggest a cross-β folding pattern
and one could reasonably expect the mechanisms of other cross-β sheet formation to
be applicable to these Cu aggregates. Current data show that Cu aggregates indeed
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exhibit Bragg peaks as compared to control tissues, which prominently appear at
3.14 Å. No diffraction rings are observed at 4.2 Å. These data demonstrate that
there is some crystalline order in Cu aggregates, which is decidedly different than
previously reported fibrillar structures from other metal-containing brain aggregates.

4.4.1

Experimental description

Measurements were made at beamline 2-ID-D at the Advanced Photon Source
with an incident energy of 10 keV and a spot size of 250×250 nm2 . An unfixed,
untreated 10 µm thick section from a 15 week old C57BL/6 mouse on thin mylar film
was first XRF-scanned. These overview scans allowed the positions of aggregates and
nearby control tissue to be recorded. Once the positions were determined, simultaneous XRF and XRD scans were carried out over the aggregate with 60 s exposure
times and 300 nm pixel sizes. The diffraction detector, a Mar165 CCD camera, was
placed 60 mm from the sample allowing diffraction to be collected over the range
1 Å < d < 7 Å. All measurements were made at room temperature in an open air
environment.
Diffraction detector calibration was done using CeO2 . A total of 385 exposures
from 3 aggregates and 272 exposures from 2 control sections were recorded. To
normalize integrated profiles for different exposure numbers, quartic fits were done
on the integrated profiles and background normalization was done using those fits.
It should be noted that X-ray induced damage is a concern and in principle could
prevent observation of the 4.2 Å ring. Diffraction from Pick bodies (another tau containing cross-β aggregate) has been reported from tissue [177]. These measurements
were made with much higher flux (>100× total dose delivered) which would rapidly
damage the sample; it is reasonable to assume that the conditions reported here do
not damage aggregates beyond observing fiber diffraction.
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Figure 4.5. XRD from Cu aggregates. A. Section of a virtual powder
stack for diffraction images recorded from Cu aggregates. The red
arrows highlight the peaks observed at 3.14 Å, which is composed of
individual Bragg peaks. B. Integrated diffraction profiles of aggregates (blue) and control tissue (green). The difference (red) shows
several peaks exist in aggregates that do not in normal tissue, the
most prominent being at 3.14 Å.

4.4.2

Results of diffraction from Cu-rich aggregates

A virtual powder stack – a sum of recorded images – of diffraction recorded from
aggregates is shown in Figure 4.5A. Some of the Bragg peaks that form a peak at
3.14 Å are highlighted with red arrows. This peak is not present in nearby control
tissue, as is evident in the integrated powder profiles (Figure 4.5B). It is noted that
two peaks are present at 5.76 Å and 5.00 Å in both aggregate scans and control
tissue scans (data not shown). Likely these are from the mylar substrate ans serve to
demonstrate the stability of integration to such high d.
While the present data is insufficient for determining the structure of Cu aggregates, it still serves an important role. The lack of a diffraction ring at 4.2 Å dismisses
the notion that Cu aggregates are formed via via cross-β sheet formation, like many
metal-containing aggregates. Amyloid-β plaques, Pick bodies, Lewy bodies, progres-
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sive supranuclear palsy plaques and corticobasal degeneration are all senile plaques
that contain cross-β sheets. Tau is expressed in astrocytes and cultured astrocytes
have demonstrated the capacity to form tau-positive fibrils in their processes as a
response to hyperphosphorylation [178,179]. While tau-induced fibril formation is an
appealing mechanism for aggregate formation, the present data suggest another, yet
to be determined, aggregation mechanism.
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5. The response of Cu in the subventricular zone to aging
and insults
One method to determine the role that Cu aggregates play in the brain is to try to
alter the Cu level in the subventricular zone through some insult (genetic mutation,
dietary modification, exogenous exposure to chemicals, etc.) and correlate altered
Cu homeostasis with other changes. The approach has been critical in determining
protein function where transgenic animals are routinely used. This chapter is devoted
to reporting the array of conditions that were investigated. First, it is shown that
Cu in the rat subventricular zone (SVZ) increases with age but not in the cortex or
other imaged regions, suggesting an SVZ-unique accumulation mechanism. Secondly,
as metallothionein has been proposed to be a feasible candidate for the binding protein (Section 4.1.2), metal concentrations for metallothionein(1,2) knockout (MTKO)
mice are characterized. While MTKO mice still exhibit periventricular Cu-rich accumulations, the overall concentration of Cu is lower and there are fewer aggregates in
the SVZ demonstrating that metallothionein plays some role in aggregate formation,
though cannot be unequivocally assigned as the binding protein. Finally, the cuprizone model for multiple sclerosis – which induces demyelination through dietary Cu
chelation – is examined and no changes in metal concentration are reported in either
the SVZ or myelin-rich regions are observed suggesting that Cu deficiency may not
be responsible for demyelination as previously assumed.

5.1

Aging results in increased Cu in the subventricular zone
One natural question to ask with respect to the role of Cu accumulations is how

concentrations vary with age. This information can be elucidating to both the aggregation mechanism as well as any biological function inclusions have in the brain. It is
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shown that Cu concentration increases with age specifically in the SVZ as compared
to regions surveyed. Furthermore, these increases correlate strongly (r = 0.99) with
a decrease in neurogenic activity in the subventricular zone.

5.1.1

Experimental description

Male SpragueDawley rats (Harlan, Indianapolis, IN.) were purchased 7-8 weeks
old and were housed in a temperature-controlled, 12/12 light/dark room, and allowed
free access to pelleted rat chow (Purina rodent chow 5001, 13 ppm Cu content) and
distilled, deionized water. This study used in total 12 rats - 3 rats each sacrificed
at the four age groups (3 weeks, 12 weeks, 16 weeks, and 36 weeks.) Sections were
prepared by the procedure described in (Section 2.5) and at stored at -80 ◦ C until
imaged.
XRF imaging was carried out beamline 10.3.2 at the Advanced Light Source [148]
and BioCAT (beamline 18-ID) at the Advanced Photon Source [180]. For beamline
10.3.2 data, Cu Kα fluorescence was recorded with a Si detector as ROI counts (i.e.
not a full spectrum) and normalized for incident intensity and collection time. For
BioCAT data, the program MAPS [120] was used to fit the spectrum at each pixel.
The results of the Cu quantitation are summarized in Table 5.1. To analyze the
Cu concentration in the intracellular compartments, areas containing Cu hot spots
were selected by identifying the pixel with maximal Cu content and then taking into
consideration all pixels with a Cu content higher or equal to half the maximum. The
average Cu concentrations were then obtained using these selected pixels.
To compare the Cu content in the SVZ of rodents of different age median thresholding was employed to isolate Cu hot spots occurring in astrocytes. Median thresholding
compares the observed concentration to the local baseline concentration by taking the
difference between that pixels concentration and the median of a 30 × 30 µm2 box
around that pixel, resulting in a peak concentration map. Analysis of aggregates was
carried out using pixels within 90% of the maximum intensity.
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For immunolabeling Ki67, frozen (-80 ◦ C) brain sections on microscope slides
were thawed, fixed with 4% paraformaldehyde (PFA) in phosphate buffered saline
(PBS) 15 minutes at room temperature (RT), washed three times with PBS, treated
for 1 hour at RT sequentially with: 1) blocking/ permeabilization solution: (2%
(w/v) bovine serum albumin (BSA) / 0.2% (v/v) Triton X-100 in PBS), 2) rabbit
anti-Ki67 at 1:300 dilution in PBS containing 2% BSA at dilutions specified in the
reagents listing, 3) Alexa Fluor 488 goat anti-rabbit IgG at 1:1000 dilution in 2% BSA.
Three, five minute washes with PBS were performed after treatment with primary
and secondary antibodies. Sections were subjected to ProLong Gold antifade reagent
before being covered with a coverslip. Slides were sealed and stored at 4 ◦ C. To
visualize immunochemical staining a Nikon Eclipse TE2000-U fluorescence inverted
microscope was used with simultaneous differential image contrast (DIC) imaging.
To quantify Ki67, fluorescing cells were counted as follows: pixels with a fluorescence
intensity above a pre-determined threshold (as shown in Fig. 4) which were isolated
were considered to be a single cell. To normalize for variations in the ventricle size
due to age, the number of fluorescing cells was divided by the length of the ventricle,
resulting in cell/µm units to express number of actively dividing cells. The ventricle
length was determined from the differential interference contrast (DIC) micrograph
with lengths derived from a camera calibration slide. The ventricles lack of tissue
provided sufficient contrast to readily determine the length using the DIC micrograph.
Analysis was carried out on three animals at each age (3, 12, 16, and 36 weeks).

5.1.2

Results of aging XRF quantitation

An analysis of the Cu content in the SVZ of animals from 3 weeks to 9 months
old showed a dramatic increase in Cu X-ray fluorescence with increased animal age
(Figure 5.1). Changes in Cu levels with age were analyzed by measuring two different
characteristics: averaged Cu concentration in SVZ (defined as 100 µm layer along the
ventricle wall from, Figure 5.1B) and Cu concentration in the aggregates (determined
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Figure 5.1. A. 3D visualization of normalized Cu Kα fluorescence
demonstrates an increased copper signal along the lateral ventricle
(lv) wall (indicated by the white line) with increased age. Data were
obtained from 30 µm thick coronal sections of the brains of 3 weeks, 3
months and 9 months-old rats. Similar distributions were observed in
all 9 animals (3 in each age group) used in this study. Experimental
details are shown in Appendix A. Insets show visualization of Ki67
proliferation marker. B. Circles (blue): Mean Cu concentration in the
SVZ as a function of age. Solid line shows fit to monomolecular growth
model (R2 = 0.944). Squares (black): Mean Cu concentrations in the
cortex of the brain. Triangles (red): Mean Cu concentrations of an
entire half-brain coronal section. The solid line in the latter two cases
shows a linear regression. It is apparent from this plot that of the
regions surveyed Cu accumulation in the brain happens largely in the
SVZ throughout aging. C. Cu concentrations in the SVZ Cu hotspots
determined by median thresholding. The linearity may suggest that
Cu accumulation above baseline levels is carried out by a mechanism
which does not change its deposition rate with time (R2 = 0.56). D.
Correlation between the Cu concentrations in the SVZ Cu hotspots
and proliferation rate (r = −0.99).

by median thresholding, see Section 5.1.1, Figure 5.1C). The observed increase in Cu
concentrations with age was fitted to two models: monomolecular growth for tissue
level images and linear dependence for 5 µm images where Cu hotspots could be
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isolated. For increase of averaged Cu concentration (Figure 5.1B) in SVZ the data
were best described (R2 = 0.944) by monomolecular growth: [Cu] = 80.08(1-exp(-(a
+ 1.377 wk)/18.03wk) (mM) while increase in Cu concentration in the aggregates was
best described by linear fit. Increases in Cu content of the SVZ were compared with
data for the cortex (Fig 4B), where essentially no large changes in Cu content were
detected. Considering the mean Cu concentration over an entire 30 µm thick coronal
half-section also showed a very small increase of Cu concentration with respect to age
as compared with growth in the SVZ.
Table 5.1.
Cu quantitation in rats
Method

Sample

Cu Concentration

AAS [181]

Plasma

15-20 µM

AAS [181]

Cerebrospinal Fluid

0.5 µM

XRF

Cu accumulations in cells

∼100-500 mM†

XRF

Cu in cells without accumulations

∼130-300 µM

†

Assumes all Cu is in 1 µm particle

Increased Cu concentration was correlated with a decrease in adult neurogenesis
(Figure 5.1D) quantified by IHC for the Ki67 proliferation marker. Strong linear
correlations were obtained for both cases of measuring averaged Cu concentration
r=-0.89 correlation (Pearson) as well as measuring increase in intensity of Cu in
aggregates r=-0.99 (Figure 5.1D). Design of a specific experiment to assess the effects
of Cu-enrichment in type B progenitors on adult neurogenesis is hindered by the
currently unknown mechanisms regulating the Cu deposition in these cells. However,
it is well known that adult neurogenesis decreases with age which is manifested in the
decrease in the self-renewal capacity and the number of SVZ progenitors [182, 183].
The mechanisms responsible for the age-related decline in the function of progenitor
cells and other progenitors remain unclear.
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The essentially linear increase of Cu concentration in aggregates with age as compared to baseline Cu levels suggests that the mechanism responsible for accumulating
Cu is unyielding with age, at least through the ages probed in this study. It has been
argued that since natural selection governs metal homeostasis only through reproductive and care-giving ages, neurological mechanisms are not well optimized for aged
life; the manifestation of the resulting unoptimized metal concentrations is neurodegenerative disease [137]. Previous studies have established that Cu homeostasis in
rats is requisite for reproduction [184] and that trace levels of Cu are necessary to perform functions required for healthy brain development [185]. Migrating neuroblasts
lack Cu accumulations (Section 3.2) implying these have been dissolved/consumed
or remain with their parent cell during division. Thus, the machinery regulating Cu
homeostasis, including Cu stores in the SVZ, in young rodents must be robust to allow
sufficient Cu for cell divisions. If that depositing mechanism is never turned off after
reproductive ages, however, Cu stores in astrocytes may grow unwieldy. Elevated oxidative stress caused by increased content of redox active metal ions, which has been
implicated in Alzheimers disease, Parkinsons disease, and several other neurodegenerative disorders [186], may be capable of preventing proliferation, explaining the
observed correlation between peak Cu concentrations and neurogenic rates (Figure
5.1D).

5.2

Metallothionein(I,II) knockout mice exhibit fewer Cu aggregates in
the SVZ
Thus far, a wealth of evidence has suggested metallothionein (MT) as a candi-

date for the binding protein for Cu aggregates. It is the only known protein that is
present in GFAP+ cells in the SVZ [187], capable of binding Cu as Cu+ [151] and
aggregating [188], and has a S/Cu ratio consistent with XRF observations (Table 4.1).
Furthermore, in situ aggregates exhibit almost identical XANES spectra compared
to ex vivo prepared Cu-MT (Figure 4.1). To determine the role metallothionein plays
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in periventricular Cu aggregates, we imaged metallothionein(1,2) knockout (MTKO)
mice. (It should be noted there are 3 isoforms of MT in the central nervous system
- MT1, MT2, and MT3. A triple knockout rodent has not been reported.) Here
we will show XRF-based analysis for age-matched MTWT and MTKO mice. It will
be shown that 1) Cu in the SVZ decreases while Zn and Fe are unaffected, 2) this
decrease is due in part to the fact that there are fewer inclusions and the present
inclusions contain less Cu, 3) remaining inclusions in MTKO mice exhibit consistent
XANES spectra compared to MTWT, and 4) in spite of decreased Cu in the SVZ,
neurogenesis is unaffected by the mutation.

5.2.1

Experimental description

Male 129S1/SvImJ (MTWT) and 129S7/SvEvBrd-MT1tm1Bri MT2tm1Bri mice –
MTKO, an MT(I,II) double knockout mouse – were purchased from Jackson Labs
[189]. Mice were sacrificed at either 4 (n = 3/3 WT/KO) or 9 (n = 3/3) weeks
old, as specified in the text. Sections were prepared using the procedure described
in Section 2.5. Imaging was carried out at several beamlines for characterization of
MTKO mice at several length scales. See Appendix A for imaging details.
XANES for wild type (WT) and MTKO mice were recorded at beamline 20-ID
at the Advanced Photon Source. 10 µm thick coronal sections from both 9 week
WT and MTKO mice were placed in a Linkam BCS196 cryostage modified to be
compatible with X-ray measurements and kept at -100 ◦ C to mitigate X-ray damage.
Samples were imaged to determine to location of aggregates from which XANES
could be recorded. Scans are calibrated using spectra recorded simultaneously from
a reference compound. Damage studies were conducted and no shift in the edge
location was detected in more than four scans per spot. The data presented in Figure
5.3 are summed from 114 WT spectra recorded from 28 spots and 28 KO spectra
recorded from 14 spots.
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For tissue-level resolved images (5 and 20 µm), regions of interest can be differentiated by comparison with a brain atlas and the average metal content of pertinent
pixels can be is readily determined. For intermediate resolution images (300-500 nm),
a static threshold of 10 µg/g was used to isolate hotspots, consistent with previous
analysis [190].

5.2.2

Results for metal quantitation of metallothionein knockout mice

For quantitative analysis, four week old MTKO knockout mice were XRF imaged
at tissue level (20 µm) resolution and compared with age matched controls. As MT
is involved with homeostasis of metals beyond Cu, the concentrations of Cu, Fe, and
Zn were characterized. Structures analyzed for differences were the striatum, corpus
callosum, cortex, and subventricular zone. XRF did not reveal any statistically significant difference in Cu or other metals for structures examined (Figure 5.2C). With
5 µm resolution, which allows finer isolation of the SVZ, Cu concentrations in the the
subventricular zone (Figure 5.2A,D) were significantly lower in MTKO mice. Thus,
the overall metal content in the brain is not drastically affected by MT (I,II) knockout, at least at 4 weeks of age. The SVZ area was also analyzed with 0.5 µm spatial
resolution, (Figure 5.2B). The number of Cu aggregates dropped considerably; there
were approximately one-third as many Cu aggregates per ventricle length in MTKO
mice as compared to wild type mice (0.152 µm−1 compared to 0.395 µm−1 ). The actual concentration of the Cu in isolated aggregates is also lower (Table 5.2). Finally,
both WT and mutant rodents exhibit a [S]/[Cu] ratio consistent with previous Cu
accumulations (Table 5.2, differences are not statistically significant). It was established earlier that Cu aggregates are localized to astrocytes we checked whether lower
number of Cu aggregates in MTKO is due to lower density of astrocytes. Staining
of WT and MTKO mice for GFAP we did not detect any differences in the density
of astrocytes in the SVZ (data not shown). Finally, quantitation of neurogenesis by
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Ki67+ cell density along the SVZ demonstrated no significant difference between WT
and MTKO (Table 5.2).
Table 5.2.
Comparison of WT and MTKO mice
WT

MTKO

Cu aggregate concentration (µg/g)∗

89.9 ± 5.97

54.9 ± 21.0

S/Cu molar ratio

1.17 ± 0.02

1.10 ± 0.10

Ki67+ cell density (cells/µm)

0.121 ± 0.014

0.129 ± 0.018

Fzd9+ cell density† (cells/µm)

0.063 ± 0.002

0.050 ± 0.007

∗

: p < 0.05, † : p < 0.10

To determine the binding environment for remaining Cu aggregates, XANES spectra were measured from both MTWT and MTKO mice aggregates. The results are
shown in Figure 5.3. Spectra from the MTWT and MTKO mice are nearly identical,
confirming that remaining clusters are Cux Sy multimetallic clusters.
The role of metallothionein in these inclusion bodies remains elusive. Renal studies
of Pb exposure found that while WT mice readily produce inclusion bodies, likely as
a means to mitigate damage from uptaken Pb, MTKO mice are unable to produce
inclusion bodies under the same conditions [188], implicating MT as a necessary
component for aggregate formation. Furthermore, transfection of MT into MTKO
cells recovered the ability to form aggregates [191]. Just as aggregates form in the
kidney in response to lead exposure, it is likely that aggregates form in periventricular
stem cells to mitigate oxidative damage from Cu uptake, relying likewise on MT to
form stable aggregates.
The Cu rich aggregates are still present in the SVZ, though, even under the
MTKO mutation (Figure 5.2). Plausibly this is a result of MT3’s presence, which is
expressed primarily in the central nervous system and not in the kidney [192, 193].
While MT’s are capable of aggregating [194,195], it has never been determined which
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Figure 5.2. Comparison of MTWT and KO metal concentration and
proliferation. A. Intensity map of normalized Cu Kα XRF with 6
µm resolution demonstrates the difference in copper concentration
along the lateral ventricle wall in control mice (WT) as compared
to MTKO mice. White dashed lines indicate the ventricle wall. B.
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mice. Images of the SVZ with 5 µm resolution show diminished Cu
concentration in the SVZ as a result of the mutation.
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isoforms facilitate aggregation; the present work suggests that MT3 alone is sufficient
for aggregate formation. One consequence of the MTKO mutation is that fewer
aggregates formed periventricularly (approximately 1/3 as many per µm. This is
likely a reflection of the fact that MT is not as readily available to promote formation
inclusion. Choudhuri et. al. [157] have reported basal relative MT isoform expression
in mouse brain to be 1.0, 0.5, and 0.7 for MT1, MT2, and MT3 respectively. In other
words MT3 expression constitutes 32% of basal brain MT expression; therefore it is
consistent that around 1/3 of the accumulations are observed.

5.3

Mn exposure does not alter Cu concentrations in the SVZ or neurogenesis
A recent article [196] presents a 40% decrease in Cu concentrations of the subven-

tricular zone (SVZ) in rats as measured by atomic absorption spectroscopy (AAS)
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attributed to subchronic manganese exposure. Furthermore, that same article reports a statistically significant increase in SVZ and rostral migratory stream (RMS)
neurogenesis measured via fluorescence intensity of antibodies for bromodeoxyuridine
(BrdU). Interested in the results but skeptical of the methodologies reported, this
study was designed to use XRF’s superior spatial resolution to validate these findings. In contrast to the reported results [196], XRF analysis data shows a small,
significant increase in Cu concentration in the SVZ following Mn treatment but only
in areas with increased Cu content. The RMS shows no changes in Cu concentration.
Additionally, neurogenic rates were measured by quantifying Ki67, which is expressed
in actively dividing cells, by cell counting. This analysis shows that Mn exposure does
not affect neurogenic rates in the adult SVZ or RMS.

5.3.1

Experimental description

Animals were prepared in the same treatment groups as those reported by [196].
In particular, male Sprague-Dawley rats were purchased from Harlan Laboratories
(Indianapolis, IN) and weighed 250 ± 10 g (mean ± SD) at the beginning of the
experiments. For one week prior to experimentation, the animals acclimated to a
temperature-controlled, 12/12-hour light/dark room, and were allowed free access to
deionized water and food. Rats in the Mn-treated group received intraperitoneal
(i.p.) injections of MnCl2 dissolved in sterile saline at a dose of 6 mg of Mn/kg
once daily for 4 weeks (1 mL/kg). This dose [181, 197] was chosen as it has been
shown give rise to blood Mn concentrations that resemble those of exposed to Mn
either occupationally or through diet [198], through liver failure [199] and amongst
methcathione users [200]. The control group received i.p. injections of sterile saline
of the same volume. Sagittal sections from Lateral ∼ 1.9 mm were taken by the
procedure described in Section 2.5.
XRF imaging was performed at beamline 8-BM of the Advanced Photon Source.
Spectra were collected per pixel (25×25 µm2 ) at an incident energy of 10 keV. The
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MAPS program [120] was used to fit the data collected. An XRF image of an AXO
thin film reference standard (Axo Dresden GmbH, Dresden, Germany) was taken
under the same experimental conditions and geometry which allowed for metal quantification.
For each individual rat sample, line plots were delineated along the SVZ or RMS
by the experimenter; the line was thickened by taking each pixel in the user-drawn line
as the center of a 7×7 pixel (150 × 150 µm2 ) box. As Cu in the SVZ is known to reside
mostly in the 100 µm nearest to the ventricle [190], selecting only high-concentration
pixels serves to spatially isolate the SVZ. To spatially isolate the localized, Cu-rich
SVZ or RMS, a Cu concentration threshold of 8.5 µg g−1 was then applied and the
average Cu concentrations determined for both experimental groups for both the
SVZ and RMS (n = 5 animals per group; see Figure 5.4E,F for an illustration).
To determine an appropriate threshold, the lowest concentration that was within
one standard deviation of the values obtained when no threshold was applied. By
this method, a concentration threshold of 8.5 µg g−1 was applied to identify Cu
accumulations in the desired region. Identified pixels were then used to quantify the
average Cu concentration.
To quantify Ki67+ cell density, 10 µm thick sections (n = 4 per group) were
removed from -80 ◦ C and allowed to thaw. Sections were then fixed using a 4%
paraformaldehyde solution for 15 minutes in followed by three, five-minute washes of
phosphate buffered saline (PBS) to remove the fixative. Sections were blocked and
permeabilized with 2% bovine serum albumin (BSA) in PBS containing Triton X-100
(0.2%) for 1 hour at room temperature. Primary anti-Ki67 antibody (1:300) diluted
in 2% BSA was applied to the sections for 2 hours at room temperature. Following
incubation of the primary antibody, sections underwent three, five-minute washes with
PBS prior to the application of secondary antibodies. Secondary antibodies (goat
anti-mouse Alexa-Fluor 488) diluted 1:1000 in 2% BSA were allowed to incubate for
an additional two hours at RT. After three, five-minute washes with PBS, coverslips
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were placed over the sections following the application of ProLong Gold antifade
reagent.
Ki67 stained sections were imaged at 10× magnification (0.65 µm / pixel) on
an upright Olympus microscope (BX43) equipped with an Olympus DP-72 camera.
Puncta of fluorescing cells were blind-counted by hand. Those counting cells were
blind to which experimental group (Mn treated or control) an image was from. A
site was considered to be a single cell nucleus if there were no strongly fluorescing
regions (above a pre-determined threshold) adjacent to it. To normalize for variations
in the ventricle or RMS size from potential sectioning artifacts or slight differences
in lateral plane location, the number of fluorescing cells was divided by the length of
the ventricle or RMS, resulting in units of (cell µm−1 ) to express number of actively
dividing cells. n = 4 animals in both the control group and treated group were
analyzed. Sequential images of the RMS and SVZ were stitched using the ImageJ
plugin by [201] with a regression threshold of 0.3 and fusion done by maximum pixel
intensity.

5.3.2

Results of Mn exposure on subventricular Cu and neurogenesis

Synchrotron XRF imaging was used to determine the distribution of elements in
the rat brain. The XRF imaging showed a strong Cu accumulation both along the
SVZ and RMS for all rat samples measured; a typical image is shown in (Figure 5.4C).
Since the full X-ray fluorescence spectrum is obtained for each pixel of this image, the
distribution of other essential elements are simultaneously recorded. These additional
elements can help in identifying the boundaries between neighboring brain regions;
for example P and Zn both provide good contrast between the corpus callosum (CC)
and the striatum (STR), between which lies the RMS.
Table 5.3 displays the average Cu content of both unthresholded and thresholded
pixels (8.5 µg/g) for both the SVZ and RMS in control and treated groups. A small
but statistically significant increase in the Cu level in the SVZ of Mn treated animals
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was observed in comparison to controls (p < 0.05) only after applying a threshold
filter. However, the Cu content of the RMS showed no changes (p = 0.40). In the
same experimental groups, a statistically significant higher Cu level was observed in
the SVZ than in RMS (p < 0.05).
To quantify neurogenesis in the SVZ and RMS, Ki67+ cells from n = 4/4 treated/
control rats were counted in 10 µm thick sections and quantified by cell counting
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Table 5.3.
Mean Cu concentrations following Mn exposure (µg/g)
No Threshold

No Threshold

8.5 µg/g Threshold

8.5 µg/g Threshold

Group

SVZ

RMS

SVZ

RMS

Control

8.58 ± 1.03

7.82 ± 2.02

12.78 ± 0.36

11.08 ± 1.06‡

Treated

9.82 ± 1.36

8.32 ± 1.94

13.72 ± 0.46∗

11.84 ± 1.19†

∗

: p < 0.05 compared to control; † : p < 0.05 compared to the SVZ of the same group

‡

: p < 0.01 compared to the SVZ of the same group

normalized by length (Figure 5.5). No significant difference was detected in either
the SVZ (p = 0.56) or the RMS (p = 0.95) suggesting that subchronic Mn exposure
does not affect adult neurogenesis in these two regions.
Regarding the effect of Mn intoxication on Cu homeostasis in the SVZ and RMS,
the present work demonstrate a 7% increase in mean Cu concentration in the SVZ
(standard deviations of 3% for both control and treated; p < 0.05) and no change in
the RMS. This is at odds with [196] which claims that SVZ Cu concentration decreases
by 41% while reporting group standard deviations of 26% and 11% respectively for
control and treated groups (p < 0.01). Animals in both cases were from the same
source and treatment group; the only difference was that [196] used AAS and this
study uses XRF. A critical difference between the methods is the accuracy with which
a given brain region can be identified. As metal distribution in the brain is spatially
capricious, [127], resolution is of the utmost importance. From 300 nm resolution XRF
maps, it is known that the dense Cu accumulations reside in a single cell layer along
the ventricle wall [190] and no reproducible methodology for SVZ extraction by hand
dissection has been reported. Experiments isolating the SVZ are of course possible
with laser capture microdissection (e.g. [202]) or when including surrounding tissue
will not critically affect results, (e.g. [203]). Studies analyzing SVZ metal composition
require incredible spatial precision and reproducibility as any accidental inclusion of

89

Figure 5.5. A. Representative Ki67 stain of the SVZ and RMS for a
control rat and B. Representative Ki67 stain for a Mn treated rat. C.
High magnification (40×) view of the RMS in a control rodent. D.
Quantitation of neurogenesis by Ki67+ cell density in the SVZ and
RMS. No significant changes are observed with n = 4 animals in each
group.

the STR in what is considered the SVZ will lead to artificially and drastically lower
Cu concentrations.
The difference in results can be rationalized as a result of the achievable resolution of hand-dissected regions for AAS. It is instructive to compare [196] and the
(untreated) rats in [204] in which brains were dissected by hand for AAS. There are
two minor differences that must be considered when comparing these studies. First,
the rats in [196] received saline injections which should have a minimal effect on
brain metal concentration levels. Secondly, rats were 14 weeks old at the time of

90
sacrifice from [196], placing them near the adult rats group in [204], and certainly
concentrations should fall between the adult and old groups. When comparing larger
structures like the hippocampal formation (0.633 µg/g vs. 0.81 µg/g) and striatum
(0.832 µg/g vs. 1.32 µg/g) it is evident that hand dissection can provide reproducible
concentrations as it has previously in elemental analysis studies. For the SVZ, a small
structure, there is almost a 20-fold discrepancy (0.928 µg/g vs. 17.8 µg/g). Barring
some accidental contamination, this discrepancy is likely a consequence of the difficulties in isolating the SVZ for AAS analysis. In contrast, X-ray fluorescence microscopy
(XRF) has spatial resolution which is limited in practice by the measurable, reproducible beam size. Our previous studies using XRF microscopy demonstrate that Cu
concentrations are consistently several orders of magnitude higher in Cu-rich accumulations in SVZ than in other brain regions (∼100-500 mM). This study shows that
Cu-rich accumulations persist along the RMS path and it has been demonstrated
that XRF is capable of detecting statistically significant changes in SVZ metal content [190]. From high-resolution XRF maps, Cu is known to reside in a single layer
nearly adjacent to the SVZ [190] and a relatively thin layer in the RMS. As a result, dependence in concentrations on the choice of ROI is eliminated by deliberately
starting with a very large ROI (±75 µm) and then applying a concentration threshold which effectively acts to spatially isolate the SVZ or RMS (Figure 5.4F). After
applying this threshold a small, but significant (p < 0.05) increase in Cu is observed,
highlighting the importance of spatial resolution when analyzing metals in such a
small, Cu rich region of the brain. XRF analysis on the striatum of this Mn exposure
model has previously been reported [205] and no significant changes in any element
except Mn were found. For Cu a slight insignificant increase was found in the striatum, but nowhere near the 40% increase reported by [196], which again is likely due
to limited dissection resolution for AAS. Similarly, this lab has reported on the HPCf
with 7 µm resolution and found no significant changes in other elements under Mn
exposure [206].
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Quantitation of neurogenesis in the SVZ and RMS showed no statistically significant difference between Mn-treated and control groups (Figure 5.5). This is in
disagreement with [196] which reports an increase in neurogenesis by measuring bulk
fluorescence of labeled antibodies sensitive to BrdU in the SVZ and RMS rather
than by cell counting. Both proliferation markers, Ki67 and BrdU, are localized to
the nucleus and thus form discrete, countable puncta under fluorescence. While cell
counting of BrdU has been reported since the initial claim of increased neurogenesis [207], it is worth considering that BrdU quantification is susceptible to artifacts
of BrdU’s uptake into the brain. BrdU is thought to be transported to the brain like
thymidine: through a carrier-mediated nucleoside transport system across both the
blood-cerebrospinal fluid (BCB) and the blood-brain barrier (BBB) [208–212]. Consequently, comparisons of neurogenesis via quantification of fluorescence intensity of
antibodies sensitive to BrdU relies on the assumption that BrdU permeability across
the BBB and BCB is unaffected by Mn exposure [213]. While there has not been
a study published that examines differential expression of nucleoside transporters at
either barrier under Mn exposure, there is a wealth of evidence that the BCB and
BBB are affected by Mn exposure. Aside from reports of increased metal transport
following Mn insult [35, 214], Santos et al. [215] also report differential amino acid
concentrations in rat brain tissue following Mn exposure. While the study was unable
to distinguish between de novo synthesis and transport across the BCB and BBB,
there remains a distinct possibility that the barriers have increased permeability after
Mn exposure. In studies where barrier integrity is uncompromised (e.g. ischemia),
Ki67 and BrdU have been shown to be present in similar ratios between control and
insulted groups [213], which is expected as Ki67 is naturally present and any attempts
to visualize the protein require steps only after sectioning.
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5.4

Cuprizone does not alter Cu concentrations in the subventricular
zone or corpus callossum
In 1969, it was first shown that dietary administration of cuprizone – a copper

chelator – induces spontaneous demyelination in the central nervous system of mice.
Removing cuprizone from the mouse’s diet also leads to remyelination [216]. The
cuprizone model reproduces many of the traits of multiple sclerosis (MS) patients:
demyelination in the corpus callosum (CC), cerebellum, and cortex as well as axon
loss are observed in both MS patients and cuprizone mice [217]. Behaviorally, both
MS patients and cuprizone mice show weight loss, diminished motor ability, and
have lower activity levels [218, 219]. As a result, cuprizone intoxication has become a
popular model for studying MS and remyelination. Despite its success, the mechanism
by which cuprizone induces demyelination is not known. The current assumption is
that Cu chelation leads to Cu deficiency which disrupts cytochrome c oxidase activity
to the extent that oligodendrocytes cannot produce adequate myelin. In support of
that hypothesis, Swiss mice have been reported to have diminished cytochrome c
oxidase activity following cuprizone administration [220]. The metal concentrations
in these demyelinated regions, however, remain unmeasured. Characterization of
cuprizone fed mice by X-ray microscopy serves two purposes. First, measurement
of Cu concentrations in demyelinated regions will be a direct test of the hypothesis
that limited Cu availability causes demyelination. By comparing XRF maps with
diffraction-formed myelin maps (Section 2.2) it is possible to correlate the presence
of myelin with metals. Secondly, it allows examination of the role that dietary Cu
plays in the formation of SVZ Cu aggregates. Data show that while cuprizone fed
mice indeed have less myelin in the CC, yet there is no corresponding decrease in
Cu. These data suggest the mechanism of demyelination may not be based on Cu
availability. In the SVZ, there are no observable changes in metal concentrations.
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5.4.1

Experimental details

Eight-week old C57BL/6 mice were fed a diet of standard rodent chow (control
group, n = 4) or that same chow with 0.2% cuprizone (treatment group, n = 4).
Mice were maintained on these diets for 5 weeks at which point they were sacrificed
and sections were prepared as described in Section 2.5.
X-ray imaging was done at the BioCAT beamline (18-ID) at the Advanced Photon
Source. The beam had an incident energy of 12 keV and was focused to a spot size
of either 25 µm × 4µm or 10 µm × 4µm. X-ray fluorescence was recorded with an
energy resolving silicon drift detector. Spectra fitting was done using the MAPS
software [120]. The diffraction detector, a Pilatus 1M, was placed 1.5 m behind
the sample with a vacuum fly tube between the sample and detector. This allows
for data collection in the range 120 Å - 11 Å. To calibrate the diffraction detector
geometry, silver behanate was used as a calibrant and calibration was carried out in
the Fit2D package [221]. For mapping experiments, ion chambers were placed before
the focusing element (I0 ) and after the sample (I1 ) and their intensities recorded at
each pixel for normalization.
Analysis of the cortex, corpus callossum, and striatum are derived from userdefined ROIs from 100 µm images. Metal concentrations in the SVZ are quantified
as described in Section 5.3.1 with the threshold being defined as the top 20% of Cu
pixel intensities.
Ki67 staining and cell counting was done as described in Section 5.3.1.

5.4.2

XRF and XRD quantification of cuprizone fed mice

XRF maps allowed quantitation of Cu in 30 µm thick sections of brains following cuprizone treatment. Of the cortex, corpus callossum, SVZ, and striatum, no
significant differences in Fe, Cu, or Zn concentrations were observed (Table 5.4).
Diffraction and XRF maps were recorded on the same samples on the same pixel
grid. In doing so, it is possible to directly correlate myelin concentrations with metal
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concentrations. The results of this analysis are shown in Table 5.4. For reference,
Figures 5.6A-C show representative myelin and XRF maps in addition to the ROI for
the corpus callossum (CC). Quantitation of myelin concentration shows a nearly 30%
decrease (p < 0.05) for cuprizone fed mice in the CC and cortex after 5 weeks of the
diet. XRF analysis in the same region shows that there is no corresponding change
in metal concentrations (Table 5.4).
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Figure 5.6. Combined XRF and XRD Analysis in the CC. A-C.
Myelin map, Cu map, and ROI selection for the CC for a representative section. D. Quantitation of metals in the CC show no significant
changes. E. Quantitation of mean myelin concentration in the CC;
differences between groups are significant at p < 0.05.
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Previous quantitation of myelination in the CC following exposure to cuprizone
at the 5 week mark have similarly shown a 30% decrease, though other studies have
shown much higher demyelination [217, 222]. The assumed, though previously unverified, mechanism behind demyelination has always been thought to be deficiency of
copper in the corpus callossum which prevents oligodendrocytes from myelin production. Oligodendrocytes are thought to comprise a majority of cells in the CC [223]
and so it would be expected that deficiency of Cu in that cell type would manifest
itself in XRF measurements. These data suggest a mechanism other oligodendrocytic
copper deficiency underlies demyelination. While this mechanism is not yet clear, it
should be determined as the cuprizone diet is commonly used to study multiple sclerosis and understanding the demyelination/remyelination mechanism will be useful
in developing clinical therapies for MS patients.
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Table 5.4.
Quantitation in cuprizone mice
Region

Control Mice

Cuprizone Fed Mice

Fe (µg/g)
Cortex

13.12 ± 2.10

11.43 ± 1.25

Striatum

12.03 ± 0.89

11.42 ± 1.16

Corpus callosum

14.14 ± 4.18

11.00 ± 1.69

SVZ

14.15 ± 3.23

13.27 ± 2.16

Cu (µg/g)
Cortex

3.15 ± 0.09

3.17 ± 0.15

Striatum

3.70 ± 0.83

3.46 ± 0.27

Corpus callosum

3.56 ± 0.56

3.75 ± 0.63

SVZ

14.38 ± 2.10

13.09 ± 1.37
Zn (µg/g)

Cortex

14.10 ± 0.35

13.25 ± 0.54

Striatum

12.97 ± 0.73

12.37 ± 0.76

Corpus callosum

14.11 ± 0.59

13.20 ± 0.90

SVZ

17.03 ± 4.80

12.28 ± 0.62

Relative Myelin Concentration
Cortex**

1.00 ± 0.06

0.75 ± 0.12

Striatum

1.00 ± 0.17

0.91 ± 0.14

Corpus callosum*

1.00 ± 0.14

0.72 ± 0.16

n/a

n/a

SVZ

Ki67+ Cell Density (cell/µm)
SVZ*

0.0539 ± 0.0078

0.0350 ± 0.0101

RMS

0.0541 ± 0.0328

0.0328 ± 0.0128

∗ : p < 0.05; ∗∗ : p < 0.01 between treatment groups
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6. Conclusions and future directions
This work has extensively used X-ray fluorescence microscopy (XRF) to characterize
Cu rich aggregates found in the subventricular zone (SVZ) of rats and mice. In addition, rats, but not mice, have Cu accumulations in the rostral migratory stream and
dentate gyrus, which may be related to the fact that the rat hippocampus produces
more neurons and new neurons are integrated more readily into neural circuits [131].
Combined XRF and immunohistochemistry enabled determination that aggregates
reside in GFAP+ cells and comparison with BrdU labeling indicates that they are
in slowly proliferating, likely type-B progenitor cells. Furthermore, Cu aggregates do
not co-localize with lysosomes nor are they immunoreactive for ubiquitin, suggesting
that the aggregates are not merely awaiting degradation but instead serve some purpose. To elucidate the binding environment XANES spectra were recorded directly
from Cu aggregates. These spectra indicate that Cu is bound as Cu+ as a Cux Sy
multimetallic cluster. Cu in these aggregates does not co-localize with other metals
but consistently co-localizes with S with a molar ratio [S]/[Cu] = 1.66 ± 0.07.
To probe the role that these aggregates may play, rodents were subjected to an
array of insults and conditions. Cu concentration increases with age specifically in
the SVZ, which can be attributed to an increase in the concentration of aggregates.
Metallothionein is a candidate for the binding protein given its affinity for binding
Cu and its [S]/[Cu] ratio. Metallotionein(1,2) knockout mice exhibit fewer aggregates
and decreased Cu specifically in the subventricular zone. Aggregates are still present,
however, which may be due to the fact that another isoform, metallothionein 3, is
present in GFAP+ cells in the subventricular zone. While these data do not permit
unequivocal assignment of metallothionein as the binding protein, they do make evident the fact that metallothionein must somehow play a role in the formation of Cu
aggregates. Other insults – dietary copper chelation and subchronic Mn exposure –
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fail to alter metal concentrations in the SVZ. Neurogenesis as measured by Ki67+ cell
density was measured for each of these conditions and insults. With the exception
of aging and cuprizone administration, in which the decrease of neurogenesis correlates strongly with increased Cu concentration (r = 0.99) though could be a result of
other aging effects, no statistically significant changes in neurogenesis were observed
in rodents.
It is interesting to speculate on the role that Cu aggregates play in these neurogenic niches. Metallothionein(1,2) knockout (MTKO) mice exhibit both decreased
Cu concentrations as well as having fewer stem cells in the SVZ as measured by
frizzled 9 (Fzd9) staining. This sugests that stem cell self-renewal is impeded as a
result of the inactivation of MT and Cu aggregate formation. One plausible mechanism is disruption of the LIF/STAT3 homeostasis. Metallothionein is known to be
induced by STAT1 and STAT3 through a binding site in its promoter region [224].
While the upstream factors governing STAT3 expression are relatively unknown, this
hypothesis suggests that there may be some feedback between MT and STAT3 expression which work to maintain appropriate balance for self-renewal of adult stem cells.
Even if expression is unchanged, a change in the phosphorylation rate of monomeric
STAT3 could account for a lack of self-renewal. Under oxidatively stressed conditions,
STAT3 phosphorylation should be increased to correlate to MT upregulation; lower
cellular oxidative stress then leads to diminished phosphorylation. This is been directly shown in a handful of systems [225,226]. It has also been shown that oxidative
stress promotes dimerization of STAT3 [227]. Both of these would encourage STAT3
translocation to the nucleus for transcription. The present data show lower metal
concentrations not only in inclusion bodies but also basally, suggesting that the cell
is less stressed oxidatively under insult-free conditions which would slow phosphorylation. From a pluripotency point of view under-phosphorylation of STAT3 would be
expected to exhibit the same overall effect as LIF deprivation, namely the inability to
self-renew and spontaneous lineage commitment. One possible role for Cu aggregates,
then, is that they form to promote self-renewal. However, the unrelenting aggregation
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mechanism discussed in Section 5.1 ultimately produces unweidly Cu aggregates in
advanced age.
While XRF has served a critical role in discovering and characterizing Cu-rich aggregates, their composition and role cannot be uniquely determined without coupling
XRF with standard bench biochemistry. As a first step, the cells which contain Cu
aggregates should be cultured. Pastrana et al. have reported a method for isolating
the major cell types in the SVZ by fluorescence-based cell sorting [228]. Isolated cells
of each type could be imaged using XRF to confirm unambiguously the cell type
which contains Cu aggregates. Furthermore, these cells could be used to produce aggregates which can be easily used for additional experiments (e.g. mass spectrometry
to determine the binding protein). Having established a culture, cells can additionally be subjected to a variety of conditions and easily probed for their response.
For example, assays designed to determine phosphorylated versus unphosphorylated
STAT3 exist and could be used to test the previous hypothesis with respect to metal
concentration. The development of beamline-compatible flow cytometers allows for
a direct probe between metal concentrations and protein composition with excellent
statistics. The results of these cytology experiments can be used to rationally design
in vivo experiments and ultimately to help in the design of new clinical therapies.
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Barbaro, Nalin Gupta, Sandeep Kunwar, Michael T Lawton, Michael W McDermott, Andrew T Parsa, José Manuel-Garcı́a Verdugo, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain
migration. Nature, 427(6976):740–744, 2004.
[83] F Doetsch, J M GarciaVerdugo, and A AlvarezBuylla. Cellular composition
and three-dimensional organization of the subventricular germinal zone in the
adult mammalian brain. Journal of Neuroscience, 17(13):5046–5061, 1997.
[84] Barbara Levinson, Christopher Vulpe, Bruce Elder, Christopher Martin, Frank
Verley, Seymour Packman, and Jane Gitschier. The mottled gene is the mouse
homologue of the Menkes disease gene. Nature genetics, 6(4):369–373, 1994.
[85] F Doetsch, I Caille, D A Lim, J M Garcia-Verdugo, and A Alvarez-Buylla.
Subventricular zone astrocytes are neural stem cells in the adult mammalian
brain. Cell, 97(6):703–716, 1999.
[86] Fiona Doetsch, Leopoldo Petreanu, Isabelle Caille, Jose-Manuel GarciaVerdugo, and Arturo Alvarez-Buylla. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron,
36(6):1021–1034, 2002.

107
[87] PJ Lucassen, P Meerlo, AS Naylor, AM Van Dam, AG Dayer, E Fuchs,
CA Oomen, and B Czeh. Regulation of adult neurogenesis by stress, sleep
disruption, exercise and inflammation: Implications for depression and antidepressant action. European Neuropsychopharmacology, 20(1):1–17, 2010.
[88] Chunmei Zhao, Wei Deng, and Fred H Gage. Mechanisms and functional implications of adult neurogenesis. Cell, 132(4):645–660, 2008.
[89] Catriona Y Logan and Roel Nusse. The wnt signaling pathway in development
and disease. Annu. Rev. Cell Dev. Biol., 20:781–810, 2004.
[90] Hitoshi Niwa, Tom Burdon, Ian Chambers, and Austin Smith. Self-renewal of
pluripotent embryonic stem cells is mediated via activation of STAT3. Genes
& development, 12(13):2048–2060, 1998.
[91] Jing Hao, Teng-Guo Li, Xiaoxia Qi, Dong-Feng Zhao, and Guang-Quan Zhao.
Wnt/β-catenin pathway up-regulates STAT3 and converges on LIF to prevent
differentiation of mouse embryonic stem cells. Developmental biology, 290(1):81–
91, 2006.
[92] Laurence Daheron, Sarah L Opitz, Holm Zaehres, William M Lensch, Peter W
Andrews, Joseph ItskovitzEldor, and George Q Daley. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells,
22(5):770–778, 2004.
[93] Ryszard Lobinski, Christophe Moulin, and Richard Ortega. Imaging and speciation of trace elements in biological environment. Biochimie, 88(11):1591–1604,
2006.
[94] WH McMaster. Compilation of x-ray cross sections. UCRL, 1970.
[95] P A Pella, D E Newbury, E B Steel, and D H Blackburn. Development of National Bureau of Standards thin glass films for x-ray fluorescence spectrometry.
Analytical Chemistry, 58(6):1133–1137, 1986.
[96] Graham Knott, Herschel Marchman, David Wall, and Ben Lich. Serial section scanning electron microscopy of adult brain tissue using focused ion beam
milling. The Journal of Neuroscience, 28(12):2959–2964, 2008.
[97] Winfried Denk and Heinz Horstmann. Serial block-face scanning electron microscopy to reconstruct three-dimensional tissue nanostructure. PLoS Biol,
2(11):e329, 2004.
[98] AS Watt. Computer-aided three-dimensional reconstruction and quantitative
analysis of cells from serial electron microscopic montages of foetal monkey
brain. Nature, 250, 1974.
[99] R Egerton. Electron energy-loss spectroscopy in the electron microscope.
Springer, 2011.
[100] Brian Jackson, Steve Harper, Laura Smith, and Jane Flinn. Elemental mapping
and quantitative analysis of cu, zn, and Fe in rat brain sections by laser ablation
ICP-MS. Analytical and bioanalytical chemistry, 384(4):951–957, 2006.

108
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Francisco Sobrino. Oxidative Stress Triggers STAT3 Tyrosine Phosphorylation and Nuclear Translocation in Human Lymphocytes. Journal of Biological
Chemistry, 274(25):17580–17586, 1999.
[227] Li Li and Peter E Shaw. A STAT3 dimer formed by inter-chain disulphide
bridging during oxidative stress. Biochemical and biophysical research communications, 322(3):1005–1011, 2004.
[228] Erika Pastrana, Li-Chun Cheng, and Fiona Doetsch. Simultaneous prospective
purification of adult subventricular zone neural stem cells and their progeny.
Proceedings of the National Academy of Sciences, 106(15):6387–6392, 2009.

APPENDIX

118

119

A. Summary of XRF images used in figures
The following is a listing of XRF images presented in this thesis and the imaging
conditions they were taken under.
Table A.1.: Details of XRF images
Image

Species

Beamline

Pixel Size (µm2 )

Energy (keV)

2.2

Rat

APS 18-ID

100 × 100

12.0

2.2

Rat

APS 18-ID

10 × 10

12.0

3.1

Rat

APS 18-ID

25 × 25

10.0

3.2

Rat

APS 2-ID-D

0.3 × 0.3

10.0

3.3A

Rat

APS 8-BM

25 × 25

10.0

3.3B

Mouse

APS 8-BM

25 × 25

10.0

3.3C

Rat

APS 8-BM

1.5 × 1.5

10.0

3.3D

Mouse

APS 18-ID

10 × 10

10.0

3.4B

Mouse

APS 2-ID-E

0.3 × 0.3

10.0

3.4D

Rat

APS 2-ID-D

0.3 × 0.3

10.0

3.5A

Rat

APS 2-ID-D

0.3 × 0.3

10.0

3.5B

Rat

APS 2-ID-D

0.3 × 0.3

13.0

3.5C

Rat

APS 2-ID-D

0.3 × 0.3

13.8

3.6B

Mouse

APS-2-ID-D

0.3 × 0.3

13.0

3.6D

Rat

APS-2-ID-E

0.3 × 0.3

13.0

4.1B

Rat

ALS 10.3.2

3×3

11.5

4.1C,D

Rat

ALS 10.3.2

3×3

(varies)

4.2A,C

Mouse

APS 26-ID

0.03 × 0.03

10.0

4.3A,D

Mouse

APS 21-ID-D

0.04 × 0.04

10.0

4.4C

Mouse

APS 2-ID-D

0.3 × 0.3

10.0
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4.5†

Mouse

APS 2-ID-D

0.3 × 0.3

10.0

5.1‡

Rat

ALS 10.3.2

3×3

11.5

5.1‡

Rat

APS 18ID

5×5

10.0

5.2A

Mouse

ALS 10.3.2

3×3

11.5

5.2B

Mouse

APS 2-ID-D

0.5 × 0.5

10.0

5.2C

Mouse

APS 18-ID-D

25 × 25

10.0

5.2D

Mouse

APS 18-ID-D

5×5

10.0

5.3A

Mouse

APS 20-ID

10 × 10

10.0

5.3B

Mouse

APS 20-ID

10 × 10

(varies)

5.4

Rat

APS 8-BM

25 × 25

10.0

5.6

Mouse

APS 18-ID

100 × 100

12.0

†

: Summed from 1s exposures at these conditions

‡

: Only 16 week old animals imaged at APS 18-ID
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